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ABSTRACT 
The objective of this thesis was to increase the understanding and assess the outcomes 
in terms of complications, relieve of symptoms and anatomical results of anterior 
vaginal wall prolapse surgery using either trocar-guided transvaginal mesh or 
conventional anterior colporraphy, and to identify variables associated with lateral 
defects.  
  A multicenter randomized controlled trial was performed between December 2007 
and December 2008 in the Nordic countries comparing transvaginal mesh surgery for 
anterior prolapse with the Prolift® mesh kit with traditional anterior colporraphy.    
Among women undergoing the above randomized controlled trial, 50 women; 27 
undergoing anterior colporraphy and 23 anterior trocar guided transvaginal mesh were 
examined at baseline with urodynamic assessment and at two months.  We found that 
trocar guided transvaginal mesh of anterior vaginal wall prolapse resulting in a 
lowering of maximal urethral closing pressures (MUCP) and increased risk for de novo 
stress urinary incontinence compared to colporraphy.  
  A prospective multicenter cohort study was performed between June 2006 and March 
2007 throughout 26 clinics in the Nordic countries.  121 patients undergoing anterior 
transvaginal mesh surgery was prospectively evaluated at baseline and one year after 
surgery using the Urogenital Distress Inventory (UDI).  Overall UDI scores declined 
from 91 before surgery to 31 one year after surgery (p<0.001). UDI subscales for 
obstructive and irritative symptoms improved one year after surgery (p<0.001 for both) 
while stress symptoms did not (p= 0.11).   
  In a subanalysis from the randomized controlled trial of mesh kit versus anterior 
colporraphy 99 patient were included diagnosed at baseline with a lateral defects in the 
anterior vaginal wall.  39 patients underwent anterior colporraphy and 60 anterior trocar 
guided transvaginal mesh surgery and one year after surgery, a persistent lateral defect 
was significantly more common after colporraphy compared to transvaginal mesh 
(11/32 (34.4%) vs 1/42 (2.4%), risk ratio 14.4 (95% CI 2.0-106.1) (P<0.001). 
  To determine variables associated with lateral defects a cross-sectional study was 
performed as subanalysis of a multicenter, randomized, controlled trial.  99 patients 
classified as having a lateral defect and 203 patients with isolated central defect of the 
anterior vaginal wall were compared with regard to clinical characteristics and 
urogenital distress.  Among the investigated patient characteristics, only hormone 
replacement therapy (HRT) use at baseline was associated with lateral defects (OR 2.7, 
95% CI 1.2-6.3) whereas previous anterior vaginal wall repair decreased the odds for 
lateral defects (OR, 0.3, 95% CI 0.1-0.9) in a multivariable model. Patients with lateral 
defects experienced more symptoms of bulging compare with patients without lateral 
defects (p=0.02). 
  In conclusion, the four studies in the thesis have shown that transvaginal mesh for 
anterior pelvic organ prolapse provides satisfactory anatomical and subjective outcome.   
However, there is an increased risk of problems with stress urinary incontinence after 
mesh surgery. In comparison with traditional surgery, prolapse surgery with mesh still 
is a new method with potential risks and benefits, especially in the long term, and must 
be carefully considered. 
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1 LIST OF ABBREVIATIONS 
 
POP Pelvic Organ prolapse 
POP-Q 
BMI 
SUI 
TVM 
OR 
RR 
CI 
ICS 
UDI 
Aa 
Ba 
C 
FDA 
TVM 
SD 
TVT 
MUCP 
 
 
Pelvic Organ prolapse Quantification 
Body Mass Index 
Stress Urinary Incontinence 
Transvaginal Mesh 
Odds Ratio 
Risk Ratio 
Confidence Interval 
International Continence Society 
Urogenital Distress Inventory 
Point A on anterior wall 
Point B on anterior wall 
Cervix or cuff 
Food and Drug Administration 
Transvaginal mesh 
Standard Deviation 
Tension free vaginal tape 
Maximal Urethral Closing Pressure 
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2 INTRODUCTION 
Pelvic organ prolapse (POP) is characterized by a downward descent of the pelvic 
organs, causing the vaginal walls or the uterus, or both to protrude. (1)  Pelvic organ 
prolapse is a common condition affecting millions of women worldwide.  In the United 
States alone, more than 300,000 surgeries for pelvic-organ prolapse are performed each 
year, of which anterior colporrhaphy for prolapse of the anterior vaginal wall 
(cystocele) is the single most common operation. In Sweden, 8,700 surgical procedures 
for pelvic organ prolapse were performed in 2010 (www.socialsyrelsen.se/statistik). 
 
POP is a condition which affects all aspects of daily function and quality of life. (2) 
Surgery remains the mainstay of treatment for POP but it is increasingly recognized  
that traditional surgical procedures often are associated with unsatisfactory outcomes.       
Because the risk of recurrence is 40% or more with traditional procedures, (3-5) there 
has been great interest in innovative surgical techniques that may improve outcomes 
after POP repair. Yet the evaluation of complex interventions has not kept pace with 
the rapid development of novel invasive therapies that involve synthetic implants.    
Several observational studies have shown lower failure rates after biomaterial-
augmented surgery, as compared with the traditional repair of POP, but data from 
randomized trials to support specific treatment recommendations have been lacking. 
 
Standardized trocar-guided mesh kits represent the most recent development in the field 
of POP surgery.  Mesh kits procedures are increasingly used in prolapse surgery, and 
the approach differs fundamentally from traditional POP repair.  These operations 
involve the use of metal trocars for placement of a synthetic mesh, which is 
standardized in shape and size, to support the vaginal walls.  Similar to the situation for 
ordinary mesh, clinical data on the safety and efficacy of mesh kits have been scarce 
and long-term outcomes are practically unknown.  The main objective of this thesis 
was to assess clinical outcomes after anterior vaginal wall prolapse surgery using either 
trocar-guided transvaginal mesh. 
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3 BACKGROUND 
3.1 Anatomy 
3.1.1 The female pelvic floor 
The pelvic floor consists of muscular and connective tissues which prevent the female 
pelvic organs from being pushed out by intra-abdominal pressure.  The pelvic floor also 
has important functions relating to sustaining urinary and fecal continence, sexual 
function and reproduction. 
 
3.1.2 The pelvic diaphragm 
The levator ani muscle consists of the iliococcygeus muscle, pubococcygeus 
(pubovisceral) muscle and the puborectal muscles.  Together with the coccygeus 
muscles, the endopelvic fascia, smooth muscles and connective tissue it forms the 
pelvic diaphragm (Figure 1).  The pubococcygeus muscles are directly attached to the 
bladder, urethra, vagina and rectum and actively contribute to visceral control.  These 
muscles are contracted at rest and act to close the genital hiatus to provide a platform 
for the pelvic organs.  The puborectal muscle forms a sling around and behind the 
rectum.  The endopelvic fascia is a sheet of connective tissue which surrounds the 
vagina and attaches the vaginal wall to the pelvic arcus tendineus fascia laterally.   
 
Figure 1. Pelvic floor, seen from above, the pelvic musculature resembles a concave 
plate.  
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3.1.3 The lateral pelvic support and urethral support structures 
A linear condensation of the obturator and levator ani fascia forms the arcus tendineus 
fascia pelvis (ATFP) – a fibrous band extending from pubic bone to the ischial spines. 
The ATFP is a supporting structure of the pubocervical and rectovaginal fascia.  The 
major components of the urethral supportive structure are the vaginal wall, the 
endopelvic fascia, the ATFP, and the levator ani muscles (Figure 2).  During cough, the 
levator ani muscle contracts simultaneously with the pelvic diaphragm and abdominal 
wall muscles to build abdominal pressure.  The levator ani contraction helps to tense 
the suburethral fascial layer, thereby increasing urethral compression. (6-8) 
 
Figure 2. Lateral view of the components of the urethral support system. 
 
 Reprinted with permission from JOL DeLancey. 
 
3.1.4 Levels of vaginal support 
In 1992, DeLancey presented a description of anatomical levels of support for the 
vagina (Figure 3). (9)  According to DeLancey the vagina has three levels of support:  
Level I suspends the upper third of the vagina and relies primarily on the uterosacral 
and cardinal ligaments; Level II is the middle third of the vagina and is suspended by 
the arcus tendineus fascia pelvis, pubocervical fascia and rectovaginal fascia; and the 
distal support at Level III which includes the pubocervical and rectovaginal Fascia, the 
pubourethral ligaments and perineal body. Deficiencies at any of the described levels 
will result in isolated, or combinations of, POP. For example, loss of level I support 
will result in uterine prolapse if the uterus is intact or vaginal vault prolapse if the 
uterus has been removed. 
   11 
 
Figure 3. Levels of vaginal support. 
 
 
 
Level I: 
The upper third of the vagina. 
The Uterosacral and Cardinal 
ligaments. 
 
Level II: 
The middle third of the 
vagina. Arcus Tendineus 
Fascia Pelvis. 
Pubocervical and 
Rectovaginal Fascia. 
 
Level III: 
Pubocervical and 
Rectovaginal Fascia (Distal) 
Pubourethral Ligament and 
Perineal Body. 
 Reprinted with permission from JOL DeLancey.   
 
3.1.5 Pelvic floor defects 
The anatomic origin of POP can be viewed as a deficiency in three different 
compartments; the anterior, posterior and the apical compartment.  The section below 
provides a brief summary of defects in the anterior compartment as described at the 
2011 ICS. (10) 
1) The lateral (paravaginal) defect occurs when the anterior vaginal wall and 
pubocervical fascia has dislodged from its lateral attachment to the ATFP on one or 
both sides (Figure 4).  This involves a level II defect. 
2) The transverse defect is a separation of the pubocervical fascia from its attachment to 
the pericervical ring of tissue at the apex of the vagina. 
3) The central defect is any break in the pubocervical fascia upon which the bladder is 
resting.  
4)  Distal defect (urethrocele) involves a herniation of the fascia supporting the distal 
urethra. 
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Figure 4. Lateral defects 
 
 
The attachments of the ATFP to the pubis and the ischial spines are intact (A).  The 
connection to the spine has been lost, allowing the fascial plane to swing 
downward (B).  (Reprinted with permission from JOL DeLancey). 
 
3.2 Epidemiology 
Pelvic organ prolapse is one of the most common indications for gynecological surgery 
but population-based epidemiological studies of the incidence and prevalence of this 
disorder are rare. (1, 11)  Pelvic floor defects in women presenting for routine 
gynecological visit is seen in 43-76% of patients, with 3-6% having descent beyond the 
hymen. (12)  In a cross-sectional study of 27,342 women age 50-79 years who 
underwent pelvic examination, 41% of women showed some degree of pelvic organ 
prolapse. (13) In Sweden, the prevalence of symptomatic POP has been estimated to 
range between 8.3% and 15%. (11, 14)  
 
A woman’s lifetime risk of surgery for pelvic organ prolapse by age 80 years is about 
7%. (15)  The peak incidence of POP surgery occur women aged 50-65 years. (11, 16)  
An estimated 13% of patients who have surgery will need a repeat operation within 5 
years. (15, 17, 18) 
 
3.3 Ethiology and risk factors 
The underlying ethiology of POP is multifactorial and many risk factors have been 
suggested. (19)  The most consistent risk factors are vaginal childbirth, advancing age, 
obesity and family history. (1, 20)  Vaginal birth increases the risk of POP by 4 to 11 
times (21) and stress urinary incontinence by 2.7 times (22) and multiple deliveries 
increases the risk for symptomatic POP. (23)  Magnetic resonance imaging (MRI) and 
ultrasound studies have demonstrated levator ani muscle defects after childbirth (24, 
25) and their association with POP and SUI. (26-28)  Decline of normal levator ani 
tone, by denervation or direct muscle trauma, results in a widened urogenital hiatus and 
weakening of the levator plate.  DeLancey et al. found that women with POP had an 
odds ratio of 7.3 for having major levator ani defects at MRI compared to women 
without prolapse. (27)  Also other environmental risk factors have been identified such 
as occupations which entails heavy lifting (29), chronic constipation (30) and genetic 
factors. (31)  Hysterectomy might increase the risk of subsequent POP but development 
of symptomatic prolapse happens many years after this procedure. (15, 21, 32)  
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Changes in endogenous collagen metabolism and reduced collagen content are 
considered an important contributing mechanism to POP. (33, 34) 
 
3.4 Symptoms 
There are several symptoms associated with POP but the most specific is “seeing” or 
“feeling” a vaginal bulge. (1, 3, 35, 36)  Other symptoms associated with POP includes 
bladder, bowel but the correlation with organ specific dysfunction is moderate. (35, 37)  
Ellerkman et al. assessed 237 women with symptomatic POP and found that 63% 
reported bulge symptoms, 73% urinary incontinence, 86% urinary urgency or 
frequency, 62% voiding dysfunction and 31% fecal incontinence. (35)  Only weak-to-
moderate correlations have been described between prolapse stage and presence of 
prolapse symptoms. (18, 35, 38, 39)  The hymen seems to be an important cut-off point 
as women with prolapse beyond the hymen have more pelvic floor symptoms and are 
more likely to report a vaginal bulge than women with prolapse at or above the hymen. 
(12, 35, 37, 40)  However, Barber et al analyzed data from 322 women with POP and 
paradoxically 17% of subjects in this population who reported vaginal bulge symptoms 
demonstrated good anatomic support (stages 0 or 1). (38) 
 
3.4.1 Urinary symptoms and prolapse 
According to the report from the ICS 2002 lower urinary tract symptoms are divided 
into three groups: storage, voiding, and post micturition symptoms.  Storage symptoms 
include increased frequency, nocturia, urgency and urinary incontinence (stress-, urge 
and mixed incontinence). (41)  POP and lower urinary tract symptoms often occur 
together. (42) (3)  In a review article, the prevalence of stress urinary incontinence 
(SUI) in patients with POP range between 13-83% . (43) SUI particularly co-exist with 
POP when the prolapse is mild. (40)  Women with POP extending beyond the hymen 
are less likely to report SUI which may be due to mechanical obstruction of the urethra. 
(39) Romanzi et al. reported that urinary obstruction occurred in 58% of women with 
grade 3 and 4  anterior wall prolapse compared with 4 % in women with grade 1 and 2 
prolapse. (44) 
 
Richardson et al. observed that loss of anterior wall descent occurred because of lateral 
detachment rather than midline stretching in women with SUI and urethral 
hypermobility. (45)  DeLancey et al. found that detachment of the arcus tendineus 
fascia pelvis (ATFP) from the spine is associated with anterior vaginal wall prolapse 
and may affect urethral support and SUI. (46, 47) 
The prevalence of women with POP who complain of urge urinary incontinence ranges 
between 21-73% in different studies. (43)  The relationship between the grade of 
prolapse and symptoms such as urgency and urge incontinence has been inconsistent in 
existing studies. 
  
3.4.2 Occult urinary incontinence 
Occult stress incontinence is defined as incontinence masked by POP in which bladder 
obstruction due to kinking or compression may prevent urinary leakage. (48)   POP 
surgery may therefore relieve the obstruction with the result of postoperative SUI in 
previously continent patients.  After POP surgeries, without concomitant anti-
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incontinence surgery, between 13% to 67% of patients develop de novo incontinence. 
(49-52)  In a 2011 Cochrane review, 187/1280 women (15%) reported de novo stress 
urinary incontinence after prolapse surgery.  De novo overactive bladder symptoms 
were noted in 103 /854 (12%) women. (53)   
 
3.4.3 Prolapse reduction tests 
Rates of urodynamic stress incontinence with prolapse reduction reported in 
symptomatically continent women with prolapse range from 25-100%. (48, 54, 55) (56-
58) In the Colpopexy and Urinary Reduction Efforts (CARE) trial they compared five 
methods of prolapse reduction in detecting occult urodynamic stress incontinence 
(Table 1). (51)  Overall, the prolapse reduction tests had a low sensitivity (5-39%) and 
high specificity (74-96%).  They found that the ability to predict postoperative 
incontinence to be variable among the five methods and the pessary prolapse reduction 
test to be least predictive one (50%) and the cotton swab test had the highest positive 
predictive value (79%).   
 
Table 1. Rates of urodynamic stress incontinence with various methods of prolapse 
reduction. 
 
Prolapse reduction Preoperative leakage with reduction 
N % 
All methods combined 112/584 19% 
Pessary 5/88 6% 
Manual 19/122 16% 
Swab 32/158 20% 
Forceps 21/98 21% 
Speculum 35/118 30% 
 
3.4.4  Clinical relevance of urodynamic investigation 
Preoperative urodynamic testing with prolapse reduction in patients with advanced 
POP is sometimes used to diagnose occult stress incontinence and in an attempt to 
predict which patient are likely to benefit from an incontinence procedure at the time of 
prolapse repair. (48, 55, 59-61)  In about 25-30% of the patients, the presence of SUI is 
not confirmed by urodynamic investigation. (62)  Urodynamic investigation may be 
bothersome for the patient and up to 63% of the patients report dysuria after the 
examination and up to 20% have urinary tract infections. (63, 64)  One study found that 
urodynamic testing before prolapse surgery was not cost-effective. (65)  Because the 
predictive ability of preoperative urodynamic testing in patients with advanced prolapse 
is poor the diagnostic value is limited and remains an area of debate.  
 
 
3.5 POP-Q 
The pelvic organ prolapse quantification system (POP-Q) was introduced 1996 by the 
International Continence Society (ICS) for description of POP. (66)  The POP-Q exam 
is used to quantify, describe, and stage pelvic support.  There are six points measured at 
the vagina with respect to the hymen and additional three points, the total vaginal 
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length, genital hiatus and the perineal body in centimeters.  Points above the hymen are 
negative numbers; points below the hymen are positive numbers (Table 2).  The POP-Q 
system has underwent extensive testing and has been shown to have exceptional intra- 
and inter-examiner reliability in four studies involving 240 subjects. (67) 
 
Table 2.  Five stages of pelvic organ support as defined by the pelvic organ prolapse 
quantitation system. 
 
Stage Definition 
0 No prolapse 
I The most distal portion of the prolapse is >1 cm above the level of the 
hymen 
II The most distal portion of the prolapse is ≤1 cm proximal or distal to the 
hymen 
III The most distal portion of the prolapse is >1 cm below the hymen but 
protrudes no further than 2 cm less than the total vaginal length 
IV Complete eversion of the total length of the vagina 
The distal portion protrudes at least the total vaginal length minus 2 cm 
beyond the hymen 
 
3.6 Recurrence and defining success 
The high rate of anatomical recurrence following traditional prolapse surgery is well 
known and especially the unsatisfactory recurrence rates after anterior vaginal wall 
repair. (18) (5, 68)  About 30% of all surgery for prolapse and urinary incontinence is a 
secondary procedure due to recurrence. (15) (69)  Anterior colporraphy is still the gold 
standard technique for anterior vaginal prolapse repair by central plication of the 
pubocervical fascia.  In randomized trials the anatomical success rate of this procedure 
ranges from 40-60%. (4, 5)  The failure rate in prolapse surgery depends on which 
definition of failure you use and whether failure is defined as subjective or objective 
failure.  The definition of surgical success after prolapse repair is not standardized and 
the results vary greatly between studies. (70)  In a study by Barber et al, 18 different 
surgical success definitions were evaluated in participants who underwent abdominal 
sacrocolpopexy.  Treatment success ranged between 19.2% and 97.2% depending on 
which definition was used.  The absence of vaginal bulge symptoms after surgery 
showed a significant association with patient’s assessment of overall improvement, 
whereas anatomic success alone did not. (38) 
 
A randomized trial that compared 3 different surgical techniques of anterior vaginal 
prolapse was conducted by Weber et al (5).  The study found that at 23 months follow-
up, POP-Q stage 2 prolapse recurrences was present in 70% patients after traditional 
anterior colporraphy, 54% after “ultralateral” anterior colporraphy, and 58% after 
absorbable mesh-augmented colporraphy.  No statistically significant differences were 
found between the groups. The definition of success that was used in the trial was based 
on recommendations of 2001 National Institutes of Health (NIH).  A secondary 
analysis of the trial of the 114 patients was performed at 2011 and then success was 
defined as 1) no prolapse beyond the hymen, 2) absence of prolapse symptoms, and 3) 
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absence of retreatment.  Eighty-eight percent of the women met this definition of 
success at 1 year. (71) 
 
3.7 Traditional surgical treatment of anterior POP 
Surgical treatment for POP can be performed either by an abdominal or vaginal route 
but the vaginal route is preferred for most procedures. (72)  There are many different 
combinations of defects in women with prolapse and combinations of surgery for 
anterior, apical or posterior vaginal wall prolapse are common.  The aim of 
reconstructive surgery is to restore vaginal anatomy while maintaining normal bladder, 
bowel and sexual function. (73)  There is a wide variety of surgical treatments but no 
consensus on which is the gold standard surgical procedure.  Traditionally, anterior and 
posterior colporraphy are among the most frequently performed operations in prolapse 
surgery. (73) 
 
3.7.1 Anterior colporraphy 
Anterior colporraphy was first described by Howard Kelly in 1914 and was originally 
an operation for stress urinary incontinence. (74)  It was designed to improve urethra 
support by plication suture at the urethrovesical angle.  The anterior vaginal wall is 
opened using a midline, sagital incision from the level of the cervix or vaginal cuff to a 
point 1.5 cm proximal to the external urethral meatus.  The vaginal epithelium is 
dissected away from the underlying anterior pubocervical connective tissue using sharp 
dissection.  The pubocervical tissue is then plicated in the midline using a series of 
interrupted or continuous delayed absorbable sutures.  The anterior wall is closed with 
an absorbable suture.  The success rate of this procedure ranges from 80–100% in cases 
series to 40–60% in randomized trials. (4, 5) 
 
3.7.2 Paravaginal repair 
The procedure is from the beginning identical to anterior colporraphy but the dissection 
extends more laterally to the ATFP where the pubocervical fascia is detached from the 
ATFP.  The sharp dissection of the vagina from the bladder fascia continues laterally 
till the pelvic side wall can be identified.  The obturator internus fascia and the ATFP 
are identified by palpation, and or visual inspection and a series of sutures are placed 
along the white line from the ischial spine to the symphysis (Figure 5 E+F).  
Paravaginal repair has a success rate between 67-100% for treatment of anterior vaginal 
prolapse, although the vaginal approach has a higher complication rate as compared to 
midline placation. (45, 75-78) 
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Figure 5. Vaginal repair in the correction of the anterior vaginal wall prolapse. 
 
 
E) Paravaginal repair with sutures have been passed through the ATFP and through the 
pubocervical fascia. 
F) Closing sutures through the pubocervical fascia and the vaginal wall. 
Reprinted with permission from Int Urogynecol J.    
 
3.8 Mesh in vaginal prolapse surgery 
Graft materials have been used to replace and reinforce native tissue since the early 20
th
 
century.  Prosthetic devices for abdominal hernia repairs have been found in ancient 
Egypt. (79)  Grafts have been used for hernia repairs with a recurrence rate of 17% 
when used for incisional hernias, after an 81-month follow-up. (80)  Permanent suture 
materials were first used in 1959 and in 1964 Ferguson was the first to introduce 
Marlex mesh. (81)  In urogynecological surgery, many grafts have been used since 
then, mainly for incontinence surgery and vaginal vault suspensions.  Since 1996, 
meshes have become increasingly popular for transvaginal surgical repair of POP. (82) 
 
3.8.1 Graft materials 
Biomaterials are defined as either biological or synthetic products used in surgery. 
Biological grafts can be further classified into autografts, allografts and xenografts.  
Autografts are harvested from the patient’s own tissues.  Allografts are taken from 
human donors (usually cadavers), whereas xenografts are taken from other species (e.g. 
porcine dermis or porcine small intestine). (83) 
Synthetic grafts can be classified as absorbable (polyglactin 910 e.g. vicryl) and 
permanent grafts (i.e. polypropylene).  Synthetic mesh has several advantages 
compared to biological grafts.  They are readily available and do not require harvesting. 
Absorbable meshes encourage fibroblast activity and because of degradation (within 
30-90 days) do not cause prolonged inflammatory reactions or infections.  These 
benefits must be weighed against limited long term support.   
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Permanent meshes (non-absorbable) are classified into four subgroups (type I-IV) 
based on the weave and pore size (Figure 6). (84)  Type I meshes are preferable over all 
other types of meshes because of less foreign body reaction, less risk for infection, 
rapid fibrinous fixation and greater tissue ingrowth compared to type II, III and IV 
meshes. (84, 85)  Macroporous grafts have a pore size of more than 75µm (86) which 
allow migration and in-growth of fibroblasts, white blood cells and vascularized tissue.  
All mesh types induce a host-vs-graft reaction with foreign body giant cells and 
lymphocytes but the severity of the reaction differs between various materials. (87, 88) 
When used for the TVT procedure, macroporous, monofilament, polypropylene mesh 
has shown beneficial characteristics as compared with other synthetic biomaterials. (60)    
Type I: Monofilament, macroporous knit which allows adequate in-growth of tissues 
and white blood cell response.  Type I mesh have the lowest risk of erosions among the 
nonabsorbable synthetic grafts. (89)  Examples Marlex, Prolene 
Type II:  Multifilament, microporous (<10 µm). Multifilament meshes cause more 
fibrosis. } E.g.GoreTex 
Type III: Multifilament. Micro- or macroporous. E.g. Teflon, Mersilene, Dacron 
Type IV: Submicronic, pore size (1 µm). Example Silicone, silicone-coated mesh. 
Rarely used in gynecological surgery. 
 
Figure 6. Classification of Biomaterials, Amid 1997  
 
 
3.8.2 Mesh surgical procedure 
The transvaginal mesh kit used in this thesis (Prolift®-system, Ethicon, Somerville, NJ) 
is a polypropylene type I mesh.  The mesh is introduced using standardized metal 
trocars and mesh extension arms extends from the central part of the mesh to the ATFP 
(Figure 7).  Four skin incisions are made in the anteromedial edge of the obturator 
foramen.  The bladder is dissected to identify the ATFP and the arms are then passed 
through the ATFP and obturator foramen by the metal trocars.  The central part of the 
mesh is positioned under the bladder after which the anterior vaginal wall is closed with 
an absorbable suture. 
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Figure 7. Anterior trocar guided transvaginal mesh. 
 
Reproduced with permission from ETHICON. 
 
 
3.8.3 Management of anterior vaginal wall prolapse 
Although data are limited, the Cochrane review from 2011 states that the polypropylene 
mesh anterior repair was superior to native tissue anterior colporraphy in reducing the 
risk of recurrent anterior compartment prolapse at objective anatomical evaluation. (53) 
Studies show high anatomical success rates ranging between 53-91%.  No study was 
able to demonstrate a difference between the methods in terms of subjective success, 
quality of life outcomes, and reoperation rates for prolapse or incontinence.  The 
dyspareunia rates were similar between the two procedures.  Table 4 shows currently 
published studies on mesh surgery of the anterior vaginal wall with more than 12 
months follow up. (90-97) 
 
3.9 Complications of polypropylene mesh in prolapse surgery 
In the literature the incidences and severity of complications varies greatly due to wide 
differences in surgical techniques, study design, methodology and follow-up time. 
Complications can broadly be classified into complications related to the surgical 
procedure and complications related to the mesh (Table 3).  
 20 
 
Table 3. Perioperative complications 
 Frequency: 
Visceral injuries; bladder, rectum and urethra  2.4-4.4%  (90, 98) 
 Haematoma requiring blood transfusion 1.4-2.5%  (98) 
Infections  2-3.8%  (98) 
 
 
 
3.9.1 Sexual function and dyspareunia 
Dyspareunia is commonly reported in women with pelvic floor disorders.(99-101)  A 
review of the effect of menopause on female sexual function found that by late 
menopause, 88% of women in the general population had sexual dysfunction with 
significant increases in dyspareunia. (99)  The rate of de novo dyspareunia after 
traditional prolapse repair ranges between 14.5-36.1%. (101-104)  Few studies address 
the problem of sexual dysfunction in women with POP after mesh surgery.  The rate of 
de novo dyspareunia or worsened pain during sexual intercourse after trocar-guided 
mesh repair ranges between 2-44%. (93-95, 105, 106)  Altman et al. reported 
deterioration in sexual function scores after mesh surgery, but not increased 
dyspareunia. (107)  However in the RCT of Altman et al 7.3% in the mesh group 
reported pain during sexual intercourse which occurred “usually” or “always” compare 
to 2% in the colporraphy group (p=0.07). (90) 
 
3.9.2 Urinary incontinence 
De novo stress incontinence rate after trocar-guided mesh repair range from 7-24%. 
(90, 97, 105, 108, 109)  In a retrospective study of 277 patients who did not have 
urinary incontinence before Prolift mesh repair, 23 patients (8.3%) underwent a 
suburethral sling insertion.(110) 
 
3.9.3 Exposures 
Mesh exposures are of major concern in mesh surgery. Exposures can occur at any time 
after surgery but are usually seen within the first year, (111)  when the vaginal mucosa 
covering the mesh becomes thinned eventually exposing the mesh. This may result in 
vaginal discharge, bleeding, pain and discomfort. Exposures usually arise in the vaginal 
walls but can also be seen in the bladder or rectum and are visualized on vaginal 
examination, cystoscopy or rectosigmoidoscopy.  Suggested risk factors are 
concomitant hysterectomy, smoking, increased BMI and age, as well as, an inverted T-
incision or proximity to the vaginal scar. (111-114)  Minor exposures often heal after 
local antibiotic or estrogen treatment, whereas larger exposures may need partial or 
total mesh excision and in rare cases extensive repeated surgery. 
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Table 4. Review of outcomes in the literature from 2008-2011 on the use of transvaginal mesh for pelvic organ prolapse 
 
Author Design Method Number of 
patients 
Follow-up 
 
Anatomical 
success (stage 0-1) 
Exposures De novo 
dyspareunia 
De novo 
SUI 
Altman 
2011 (A) 
RCT Mesh (Prolift®) 200 1 year 82.3% 11.5% 7.3% 12.3% 
Traditional repair  47.5%  2% 6.3% 
Withagen 
2011 (A+P) 
RCT Mesh (Prolift®) 58 1 year 90.4% 16.9% 8% 12%* 
Traditional repair 56 54.8%  10% 11% 
Sivaslioglu 
(2008) (A) 
RCT Mesh (Parietene®) 45 1 year 91% 6.9% 4.6% 0% 
Traditional repair 45 72%  7% 
Cosson 
2010 (A+P) 
Prospective 
cohort 
Mesh 
(Gynemesh®) 
90 3 years 80.0% 14.4% 8.8% NR 
Moore 
2010 (A) 
Prospective 
cohort 
Mesh 
(Perigee®) 
114 2 year 88.5% 
 
10.5% 6.4% NR 
Nieminen 
2010 (A) 
RCT Mesh (Parietene®) 105 3 years 87% 19% 4%* 7% 
Traditional repair 97 59%  8% 5% 
Elmer 
2009 (A) 
Prospective 
cohort 
Mesh (Prolift®) 121 1 year 
 
79% 11%  17% 
Carey 
2009 (A+P) 
RCT Mesh 
(Gynemesh®) 
69 1 year 81%* 5.6% 27.8% NR 
Traditional repair 70 65.6%  41.7% NR 
Nguyen 
2008 (A) 
RCT Mesh (Perigee®) 38 1 year 87% 5.4% 8.7% NR 
Traditional repair 55%  15.4% NR 
A= Anterior repair, P= Posterior repair. NR= not reported.   * Not statistically significant (p≥0.05). 
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4 AIMS 
The overarching aim of this thesis was to study the clinical outcomes of trocar guided 
transvaginal mesh surgery in women with anterior vaginal wall prolapse.  The specific 
aims were: 
 
1. To investigate the urodynamic effects of anterior vaginal wall prolapse surgery 
using either trocar guided transvaginal mesh or colporraphy. (Paper I) 
 
2. To assess the effects of trocar guided transvaginal mesh on lower urinary tract 
symptoms after anterior vaginal wall prolapse repair. (Paper II) 
 
3. To evaluate objective and subjective outcomes following use of transvaginal 
mesh compared with traditional colporraphy for repair of anterior vaginal wall 
lateral defects. (Paper III) 
 
4. To compare clinical characteristics and symptoms among patients with isolated 
central defects and patients with a combination of both central and lateral 
defects. (Paper IV) 
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5 PATIENTS 
Paper I, III and IV are ancillary studies to a multicenter, randomized, controlled trial 
comparing the use of trocar-guided, transvaginal polypropylene-mesh repair kit and 
traditional colporraphy in women with prolapse of the anterior wall. (90) The study was 
performed at 53 hospitals in Sweden, Norway, Finland and Denmark from December 
2007 through December 2008.  In all, 1,685 patients were screened for enrollment of 
which 389 women were randomly assigned to treatment: 200 patients underwent 
transvaginal mesh kit repair and 189 patients underwent traditional colporraphy.  The 
study included patients at least 18 years of age who presented with symptomatic 
primary or recurrent prolapse of the anterior vaginal wall ≥ 2 POP-Q stage.  Exclusion 
criteria included previous cancer of any pelvic organ, systemic glucocorticoid 
treatment, insulin-treated diabetes, an inability to participate in study follow-up or to 
provide informed consent, or the need for concomitant surgery.  The primary outcome 
was a composite of objective POP-Q stage 0-1 and the subjective absence of symptoms 
of vaginal bulging.  
 
 
 
 
 
 
Figure 8. Disposition of patients in paper I, III-IV. 
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5.1 Paper I 
The study population was enrolled at five hospitals in Sweden ( Södersjukhuset, 
Danderyd hospital, University hospital at Huddinge and University hospital at 
Akademiska in Uppsala) and Denmark (Roskilde university hospital) and was a 
substudy to the larger RCT (see Figure 9).  50 patients underwent randomization: 27 
patients underwent anterior colporraphy and 23 patient’s trocar-guided transvaginal 
mesh.  Mean age at the time of surgery was 66.3 (SD±10.8) years in the colporraphy 
group and 67.9 (SD± 11.3) years in the mesh group. 
 
Figure 9. Randomization and follow-up of the study patients.  
Study population
n=52
n=2 declined
Randomisation 
n=50
Group 1
n=27*
Group 2
n=23
Completed baseline 
urodynamics
2 months follow-up 
n=26
1 lost to 
follow up
1 lost to 
follow up
2 months follow-up 
n=22
 
* One patient excluded from analyses because a prolapse pessary was not removed at 
the time of urodynamic assessment. 
 
5.2 Paper II 
Paper II is an ancillary study to a prospective multicenter cohort study performed 
throughout 26 clinics in Sweden, Denmark, Finland, and Norway from June 2006 
through March 2007.  Patients with symptomatic pelvic organ prolapse stage 2 or more 
were invited and during the study period, a total of 261 patients were included (of 
which nine patients were excluded due to missing information).  The 1-year follow-up 
visit was attended by 232 (89%) patients.  Anterior repair with mesh was performed in 
121 of 261 patients (48%).  The study population in paper II was restricted to women 
undergoing anterior repair with mesh with anterior vaginal wall prolapse stage ≥2 
according to POP-Q (n=121).  Eight patients were excluded from analysis due to 
incontinence surgery prior to the study, three patients because of stress urinary 
incontinence surgery performed within 2 months of the operation, and one patient was 
excluded due to erroneous data. In all, 109 patients with a mean age of 66.0 years (SD 
±8.4) were available for analysis and 99 (91%) attended the 1-year follow-up visit. Of 
the 109 patients, 64 (59%) underwent surgery as a secondary procedure because of 
prolapse recurrence.   
   25 
 
5.3 Paper III and IV 
Of the 389 patients randomized and treated in the main study, 302 (78%) were 
examined for lateral defects at baseline.  Of these patients, 99/302 (33%) were 
classified as having a lateral defect and 203/302 (67%) were classified as having no 
lateral defect.  Paper III and IV include the 99 patient’s positive for lateral defects at the 
baseline clinical examination, 39 underwent anterior colporraphy and 60 anterior trocar 
guided transvaginal mesh.  Of the 99 patients, 36 (36%) underwent surgery as a 
secondary procedure because of prolapse recurrence.  Twenty five patients were not 
examined for lateral defects postoperatively and were excluded from the final analysis. 
These patients did not differ with regard to baseline characteristics.  Mean age at the 
time of surgery was 64 (SD±9.4) years in the colporraphy group and 63.6 (SD±9.6) 
years in the mesh group. 
 
In paper IV the study population was derived from the same population as the study 
group in paper III but the inclusion criteria’s were modified.  In paper III we only 
included patients classified as having a lateral defect (n=99) but in paper IV we also 
included patients classified as having no lateral defect (n= 203) as controls.  The final 
study population consisted of 302 women examined for lateral defects at baseline. 
Mean age at the time of surgery was 64 (SD±10.1) years in patients classified as having 
no lateral defect and 63.8 (SD±9.5) years in patients classified as having a lateral 
defect. 
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6 METHODS 
Study design 
Ethical approval from Research Ethics Committee at Karolinska Institutet was obtained 
prior to initiation of all studies (ethical permit numbers 2007/783-31/3 paper I, III and 
IV, 2006/382-31 paper II. 
 
6.1 Paper I 
A prospective, randomized multicenter trial evaluating the urodynamic effects of 
anterior vaginal wall prolapse surgery using either trocar guided transvaginal mesh or 
colporraphy.  Clinical examination, subjective symptom, and urodynamic assessments 
were performed before surgery and at two months postoperatively (section 6.5). 
Methods, definitions, and descriptions of the urodynamic investigation conformed to 
the standards recommended by the International Continence Society.  Trial protocols 
were send to the clinical research unit at the Department of Obstetrics and Gynecology, 
Danderyd Hospital, Stockholm, Sweden, and only the principal investigators had access 
to the data.  All gynecologists participating in the trial were experienced pelvic 
surgeons and had pretrial, supervised, hands-on training in operating room sessions.  
The transvaginal mesh company had no influence over study aim, design, analysis and 
interpretation of data. 
 
6.2 Paper II 
This was a multicenter, prospective cohort study to assess the effect of trocar guided 
transvaginal mesh on lower urinary tract symptoms after anterior vaginal wall prolapse 
repair.  All participants underwent anterior transvaginal mesh surgery using the trocar 
guided Prolift®-mesh kit and completed the validated Urogenital Distress Inventory 
(UDI) (section 6.5.4) before surgery and after one year.  
 
6.3 Paper III 
This was a secondary analysis from a randomized controlled trial of mesh kit versus 
anterior colporraphy.  This parallel cohort study with randomized treatment allocation 
included 99 subjects diagnosed with a lateral anterior vaginal defect at baseline.  
Thirty-nine underwent anterior colporraphy and sixty anterior trocar guided 
transvaginal mesh surgery.  Clinical examination (section 6.5.1 and 6.5.2) and 
subjective symptom assessments (section 6.5.4) were performed before surgery and one 
year postoperatively.   
 
6.4 Paper IV 
This was a cross sectional study and pre-decided subanalysis of a multicenter, 
randomized, controlled trial performed at 53 hospitals throughout Sweden, Norway, 
Finland and Denmark.  The study population consisted of 302 women examined for 
lateral defect at baseline.  Clinical examination and subjective symptom assessments 
were performed before surgery.  
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6.5 Clinical examination 
6.5.1 POP-Q 
Before surgery all patients underwent a gynecological examination in the supine 
position using the POP-Q system. (66)  Methods, definitions, and descriptions 
conformed to the standards recommended by the ICS. (66)  In prolapse surgery there is 
no universally accepted definition of failure and the POP-Q system does not include a 
definition of optimal vaginal topography.  For the purpose of the studies presented in 
this thesis, the hymen plane was considered the point of reference for failure.  Thus, 
recurrence of prolapse after surgery was defined as point Ba at the hymen or beyond 
(Ba≥0) (i.e. surgical failure) and no recurrence was defined as point Ba positioned 
proximal to the hymen (Ba<0). Postoperative point Ba proximal to the hymen (Ba<0) 
was considered anatomical cure.  POP-Q measurements and staging at pre- and 
postoperative examinations were recorded in a separate protocol.  
 
6.5.2 Lateral defects 
The measurements of lateral defects are not included in the POP-Q system and there is 
no validated developed test to assess lateral defects.  In the present studies we examined 
for lateral defects with the patient placed in the supine position.  A speculum was used 
to depress the posterior vaginal wall after which a ring forceps was placed vaginally 
toward each ischial spine in an attempt to reduce the prolapse.  The patient were 
straining when performing the lateral defect characterization.  If the prolapse was 
completely reduced on one or two sides when ring forceps were applied the patient was 
positive for a lateral defect.  The data on lateral defects were recorded prospectively as 
part of the protocol.   
 
6.5.3 Urodynamics 
Methods and guidelines from International Continence Society (ICS) were used for 
urodynamic measurement with uroflowmetry, filling cystometry, and combined 
pressure-flow studies. (115, 116)  
 
Uroflowmetry  
Uroflowmetry measures the flow rate (Q) of the urinary stream as volume per unit time 
in milliliters per second, (ml/s) and is performed to demonstrate the result of the 
emptying phase of the micturition cycle.  The patient was asked to void when she felt a 
“normal” desire to void. Normal voiding occurs when the bladder outlet relaxes (is 
passive) and the detrusor contracts (is active).  The flow patterns are described as 
continuous or intermittent. 
 
Filling Cystometry 
Cystometry was performed at a filling rate of 50 ml/minute to evaluate the storage 
phase of the micturition cycle and provided information on the capacity of the bladder 
(Maximum Cystometric Capacity) and the transmission of sensation through the 
neurosensory pathways (first sensation, first desire, strong desire and urgency).  Stress-
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test was performed at every 100 ml infused and if urinary leakage was observed in the 
absence of detrusor contractions the patient was diagnosed with SUI. 
 
Urethral pressure  
Urethral pressure measurements were used to assess urethral closure and voiding 
function. Urethral pressure is defined as the fluid pressure needed to open a closed 
urethra.  The urethral pressure profile was measured along the whole length of the 
urethra. The simultaneous recording of both urethral (pura) and intravesical pressure 
(pves) enables calculation of urethral closure pressure, i.e., pura minus pves.  Before 
maximum urethral closure pressure (MUCP) was determined, the volume was reduced 
to approximately 300 ml.  The MUCP was determined while withdrawing the 
profilometer at 1mm/sec. The cough provocation test consisted of repeat coughing in a 
seated position.  After voiding was complete the patient was catheterized and PVR 
urine was recorded.  
 
6.5.4 Urogenital Distress Inventory 
We used the UDI to collect data on lower urinary tract function and symptoms in paper 
II, III and IV. (117)  We used the full version of the UDI which consists of 19 questions 
covering 3 domains of lower urinary tract function: symptoms related to stress urinary 
incontinence, detrusor overactivity, and bladder outlet obstruction.  Response 
alternatives are measured on an ordinal scale based on frequency of symptoms.  Self-
reported bother caused by specific symptoms are recorded on a four- point scale with 
response alternatives ranging from 0 = not at all, 1= slightly, 2= moderately to 3 = 
greatly.  The UDI consists of three subscales (each ranging from 0 to 100, with a 
maximum summary score of 300): irritative symptoms (UDI-I), obstructive discomfort 
(UDI-O), and stress symptoms (UDI-S).  Higher scores indicate greater dysfunction.  
Data on the reliability, validity and sensitivity to change of these measures demonstrate 
that they are psychometrically strong. (117) 
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7 STATISTICAL ANALYSES 
 
7.1 Paper I 
Baseline characteristics are presented using absolute and relative frequencies 
(categorical variables) with either means and standard deviations (SD) or medians with 
ranges as appropriate.  Non-parametric data were analyzed by using Wilcoxon signed 
rank test for dependent, and Mann-Whitney U-test for paired independent, samples.  
Fischer’s exact or X² test was used for comparisons between proportions.  All analyses 
were performed blinded to treatment allocation.  Analyses were by intention to treat.  
One patient randomized to colporraphy underwent an anterior trocar-guided mesh 
procedure due to a misunderstanding at the trial site and this patient was analyzed as 
originally randomly assigned. We performed a statistical power analysis prior to the 
trial assuming a 25% difference in the proportion of patients with postoperative MUCP 
< 40 mm H2O, with β=0.8 and α=0.05.  A sample size of at least 20 patients in each 
treatment arm were then required.  Data were analyzed using SPSS version 17 software 
(Chicago, IL) and P-values < 0.05 were considered statistically significant for all 
comparisons.  
 
7.2 Paper II 
Analyses were restricted to patients responding to the questionnaires.  Non-parametric 
continuous data were analyzed using the Mann-Whitney U-test for independent 
samples and Wilcoxon signed rank test for within group comparison.  Fischers exact or 
χ2 test was used for comparisons between proportions when appropriate.  Data were 
analyzed using SPSS® version 17 software (Chicago, Ill., US) and p-values < 0.05 
were considered statistically significant for all comparisons. 
 
7.3 Paper III 
Baseline characteristics are presented using absolute and relative frequencies 
(categorical variables) with either means and standard deviations (SD) or medians with 
ranges as appropriate.  The differences in UDI summary scores between groups were 
tested using the Mann-Whitney U-test. Comparisons of proportions of patients with 
lateral defects pre- and postoperatively were tested with Fischers exact test and 
presented as risk ratio with the 95% confidence intervals (CIs).  Data were analyzed 
using SPSS® version 18 software (Chicago, Ill., US) and p-values < 0.05 were 
considered statistically significant for all comparisons.    
 
7.4 Paper IV 
Potential risk factors were assessed in uni- and multivariable models to determine the 
association with lateral defects: age, parity, body mass index (BMI), smoking, hormone 
replacement therapy (HRT), POP-Q staging of the anterior vaginal wall, previous 
anterior wall repair, previous posterior wall repair and previous hysterectomy.  The 
continuous variables age and BMI were included partly as linear continuous variables 
(linearity was assessed by means of the partial residuals), and partly categorized using 
restricted cubic splines with 4 degrees of freedom.  The Hosmer-Lemeshaw godness-
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of-fit test was performed for the multivariable models and outliers were checked by 
means of the df-betas whereas the variance inflation factor (VIF) was used to detect 
possible multicollinearity. Interactions were tested for within the multivariable model.  
Data were analyzed using SPSS® version 18 software (Chicago, Ill., US) and R v2.9.2 
(R.Foundation for Statistical Computing, Vienna, Austria) and p-values < 0.05 were 
considered statistically significant for all comparisons.  Mann-Whitney U-test was used 
for comparing UDI-scores between groups.  
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8 RESULTS 
8.1 Paper I 
8.1.1 Patient characteristics 
Fifty patients underwent randomization and underwent standardized urodynamics 
preoperatively and at two months after surgery.  One patient randomized to colporraphy 
underwent an anterior trocar guided mesh procedure due to a misunderstanding at the 
trial site and because we applied intention to treat analyses this patient was analyzed as 
she was randomized.  27 patients were randomized to colporraphy, one patient was 
excluded from analyses because a prolapse pessary was not removed at the time of 
urodynamic assessment, and one patient did not want to undergo postoperative 
urodynamics.  In total 25 (92.6%) patients in the colporraphy group were available for 
final analysis.  In the mesh group 23 patients were randomized and one patient declined 
urodynamic assessment at the two months follow-up bringing a total of 22 (95.6%) 
patients available for final analysis.  Age, BMI, number of overall parity, previous 
hysterectomy, and prolapse and incontinence surgery did not show any significant 
difference between the colporraphy and the transvaginal mesh group at baseline.  
Detailed descriptive data and statistical comparisons are presented in Table 5.    
 
Table 5.  Baseline characteristics 
 Colporraphy 
(n= 27) 
Transvaginal mesh 
(n= 23) 
p-value 
Age (mean±SD)  66.3±10.8 67.9±11.3 0.76 
BMI (mean±SD) 24.7±3.2 25.7±3.5 0.28 
Parity, median (range) 2 (1-5) 2 (0-4) 0.89 
Previous surgery 
number of patients (%) 
8 (30) 8 (35) 0.97 
Prolapse surgery 2 (7) 4 (17) 0.39 
Incontinence surgery 1 (4) 1 (4) 1.0 
Hysterectomy 5 (18) 3 (13) 1.0 
SD, standard deviation; BMI, body mass index. 
Comparison between the two group’s characteristics at baseline using Mann-Whitney 
or Fischer’s exact or X² test was used for comparisons between proportions. 
 
8.1.2 Urodynamic results 
Table 6 shows the urodynamic findings before and after surgery in the colporraphy and 
the transvaginal mesh group.  In the colporraphy group there were no significant 
differences in any of the urodynamic variables when comparing pre- with postoperative 
measures.  After both anterior colporraphy and anterior trocar-guided transvaginal 
mesh there was an overall decrease in MUCP, although not statistically significant 
(p=0.3 and 0.07, respectively) (Figure 10).  Foremost there was a shift in the 
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distribution of MUCPs quartiles toward a lower range of values (p= 0.008).  After 
transvaginal mesh surgery the number of patients with MUCP< 40 cm H2O increased 
although not at a significant level (p=0.18) but the number of patients with objective 
leakage at postoperative cough provocation increased significantly (p=0.016). 
 
Figure 10.  MUCP median  preoperatively and at 2 months follow-up 
 
 
 
There was no significant differences in-between the groups with regard to postvoidal 
residual urine (PVR), maximal urine flow (Q-max), maximal cystometric capacity 
(MCC), sensation, detrusor contraction or MUCP postoperatively.  There were, 
however, a significantly increased number of patients with de novo leakage at cough 
provocation after transvaginal mesh surgery when compared to colporraphy: de novo 
leakage at cough provocation was observed in 2/25 (8%) women after colporraphy and 
7/22 (32%) women after transvaginal mesh (p=0.038) (Figure 11).  Among the nine 
women with de novo leakage at cough provocation: six had a MUCP< 40 cm H2O; six 
had a BMI>25; and all patients were 65 years or older. 
P=0.07 
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Table 6. Comparison Between Pre- and Postoperative Urodynamics 
 
 Colporraphy 
 
 Transvaginal mesh  
 Preoperatively 
n=26 
 
Postoperatively 
n=25 
p-value Preoperatively 
n=23 
Postoperatively 
n=22 
p-value 
PVR (ml) 30.0 (0-150) 12.5 (0-200) 0.094 30.0 (0-150) 20.0 (0-200) 0.71 
Q-max (ml/sec) 17.8 (7-48) 16.5 (5-36) 0.22 14.5 (3-33) 17.1 (6.6-48) 0.59 
MCC (ml) 403 (253-573) 403 (176-562) 0.91 418 (191-811) 407(186-698) 0.18 
First desire to void (ml)  243 (68-465) 242 (80-438) 0.69 248 (97-475) 226 (111-403) 0.56 
Strong desire to void (ml)  354 (157-560) 345 (126-531) 0.98 390 (172-563) 354 (164-626) 0.70 
Detrusor contraction during 
bladder filling 
(n affected/ n measured) 
1/25 2/24 1.0 1/22 1/21 1.0 
MUCP (cm H2O) 41.5 (23-98) 39.0 (5-100) 0.30 44 (6-69) 29.5 (14-79) 0.075 
MUCP < 40 n (%) 12 (46) 13 (50) 1.0 9 (41) 13 (65) 0.18 
MUCP < 28 1:st percentile 9 (34.6) 7 (26.9)  
0.39 
5 (22.7) 10 (50)  
0.008 MUCP < 43 2:nd percentile 15 (57.7) 16 (61.5) 10 (45.5) 15 (75) 
MUCP < 53 3:rd percentile 21 (80.8) 20 (76.9) 16 (72.7) 16 (80.1) 
Leakage at cough  
(n affected/ n measured) 
3/25 3/25 1.0 1/22 7/22 0.016 
 
PVR, postvoidal residual urine; Qmax, maximal urine flow; MCC, maximal cystometric capacity; MUCP, maximal urethral closing pressure. 
Values are median (range) unless stated otherwise.  Comparison between pre- and postoperative values using Wilcoxon signed rank test or χ2 test.  
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Figure 11.  De novo leakage at cough after Colporraphy and Transvaginal Mesh (%) 
 
 
 
 
8.1.3 Stress urinary incontinence symptoms 
Data from the stress subscale (UDI-S) of the UDI for the two groups showed that in the 
colporraphy group the UDI stress subscale improved from 33 (range 0-100) 
preoperatively to 8 (range 0-83) (p=0.06) at the two months follow-up.  In the mesh 
group the UDI stress subscale did not change significantly from 16 preoperatively 
(range 0-100) to 17 two months postoperatively (range 0-100) (p=0.1).  There were no 
significant differences between the two groups when comparing the distribution of 
UDI-S at two months follow-up, median 8 months (range 0-83) vs.  17 months (range 
0-100) (p=0.09) in the colporraphy and mesh group respectively.    
8% 
32% 
P=0.04 
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8.2 Paper II 
8.2.1 Study group characteristics 
109 patients were available for analysis and 99 (91%) attended the 1-year follow-up 
visit.  UDI scores could be calculated for 96 patients preoperatively and for 94 patients 
postoperatively.  Mean age± (SD) age at surgery was 66±8.4 years, mean BMI was 
27.1±4.2 and median parity was 2 (range 0-5).   
The majority of patients had undergone previous pelvic surgery and transvaginal mesh 
surgery was performed as a secondary procedure in a total of 64 (59%) patients.   
Detailed cohort demographics are presented in Table 7.   
 
Table 7.  Patient characteristics 
 Anterior repair  
(n=109) 
 
Age (y) 66±8.4 
Parity 2 (0-5) 
Body mass index 27.1±4.2 
Smoker  
Yes 9 (9) 
No 99 (91) 
Menopausal  
Yes 105 (96) 
No 4 (4) 
Hormone therapy  
Local 43 (40) 
Systemic 29 (27) 
Previous pelvic surgery  
Hysterectomy 50 (46) 
Prolapse 64 (59) 
Salpingo-oophorectomy 25 (23) 
Concurrent surgery 20 (18) 
Cervical amputation 1 (1) 
Enterocele obliteration 1 (1) 
Vaginal hysterectomy 3 (3) 
Perineorraphy 5 (5) 
Posterior colporraphy 8 (7) 
Sacrospinous fixation 2 (2) 
 
Figures are mean± standard deviation, median (range), or n (%). 
 
 
 36 
 
8.2.2 Urogenital Distress Inventory (UDI) 
Item-specific outcomes for the UDI with comparisons between pre- and postoperative 
scores are presented in Table 8.  Postoperatively, there were significant decreases in 
all lower urinary tract symptom scores with the exception of leakage related to physical 
activity (P= 0.34), bedwetting (P= 0.09), and large and small amounts of urine leakage 
(P= 0.1 and 0.23, respectively).  All items of the obstructive subscale improved 
significantly 1 year after surgery.  Figure 12 is a box plot graph, illustrating the overall 
UDI preoperatively and at 1-year follow-up visit after surgery as medians with upper 
and lower quartiles.  The overall UDI declined from 91 at baseline to 31 one year after 
surgery (p<0.001).  
 
Figure 12.  Box-plot graph of overall UDI at baseline and at the 1-year follow-up 
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Table 8. Item specific outcomes according to the Urinary Distress Inventory 
 
Do you experience, and, if so, 
how much are you bothered 
by: 
Scale 
domain¹ 
Preoperative 
score 
 
1 year follow-
up 
score 
 
P-value 
Frequent urination?  I 1.5±1.1 0.7±0.9 < 0.001 
A strong feeling of urgency 
to empty your bladder?  
I 1.5±1.2 0.6±0.8 < 0.001 
Urine leakage related to the 
feeling of urgency?  
I 1.1±1.1 0.5±0.7 < 0.001 
Urine leakage related to 
physical activety, coughing 
or sneezing?  
S 0.8±0.9 0.8±1.0 0.34 
General urine leakage not 
related to urgency or activity?   
O 0.5±0.8 0.3±0.5 0.003 
Small amounts of urine 
leakage drops?  
S 0.5±0.8 0.3±0.6 0.10 
Large amounts of urine 
leakage?  
I 0.5±1.0 0.4±0.7 0.23 
Nighttime urination?  I 1.4±1.1 0.9±0.8 < 0.001 
Bedwetting?  I 0.1±0.3 0.1±0.3 0.1 
Difficulty emptying your 
bladder?  
O 1.1±1.1 0.4±0.8 < 0.001 
Feeling of incomplete 
bladder emptying?  
O 1.2±1.07 0.4±0.7 < 0.001 
Lower abdominal pressure?  O 1.2±1.2 0.3±0.6 < 0.001 
Pain when urinating?  O 0.3±0.6 0.04±0.2 < 0.001 
Pain in the lower abdomen or 
genital area?  
O 0.4±0.9 0.1±0.3 < 0.001 
Heaviness or dullness in the 
pelvic area? 
O 1.4±1.1 0.3±0.6 < 0.001 
A feeling of bulging or 
protrusion in the vaginal 
area?  
O 2.1±1.1 0.3±0.8 < 0.001 
Pelvic discomfort when 
standing or physically 
exerting yourself?  
O 1.6±1.1 0.3±0.6 < 0.001 
Push on the vaginal walls to 
have a bowel movement?  
O 0.6±0.9 0.3±0.6 0.007 
Data are mean± standard deviation.   
¹Subscale domains of the Urinary Distress Inventory: I= Irritative Symptoms; S= Stress Symptoms; O= 
Obstructive/Discomfort. 
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8.2.3 UDI subscales 
Figure 13 shows box plot graphs of the three domains: symptoms related to bladder 
outlet obstruction (UDI-O), detrusor overactivity (UDI-I), and stress urinary 
incontinence (UDI-S), preoperatively and one year after surgery.  In the irritative 
subscale the UDI decreased from 28 (range 0-100) to 11 (range 0-67) (p<0.001), the 
obstructive subscale from 33 (range 0-95) to 3 (range 0-50) (p< 0.001) and the stress 
subscale from 17 (range0-100) to 0 (range 0-83) (p=0.11).  
 
Figure 13.  Box plot graphs for comparison of  the UDI subscales at baseline and at the 
1-year follow-up 
 
 
 
 
 
UDI in relation to anatomical outcome 
Table 9 describes the UDI subscales preoperatively and at 1-year in relation to the 
anatomical outcomes after anterior transvaginal mesh surgery.  Regardless of 
anatomical outcomes the irritative and obstructive subscales improved significantly one 
year after surgery with major improvements in average scores.  For the stress subscale 
neither overall scores, nor the score in women with point Ba -1 cm or less proximal to 
the hymen, changed significantly one year after surgery. 
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Table 9.  Comparison of outcomes in median with range of the Urinary Distress Inventory (UDI) 
and Subscales in relation to point Ba. 
 
UDI Preop 
Overall 
(n=96) 
1 year 
FU 
p-
value 
Successful at 1 year follow-up 
(Point Ba-1cm or less) (n=72) 
Failure at 1 year follow-up 
(Point Ba 0 or more) (n=22) 
Preop 1 year p-value Preop 1 year p-value 
UDI- I 
(0-100) 
28 
(0-100) 
11 
(0-67) 
<0.001 
28 
(0-100) 
13 
(0-58) 
<0.001 
28 
(0-100) 
11 
(0-47) 
<0.001 
UDI-O 
(0-100) 
33 
(0-95) 
3 
(0-50) 
<0.001 
33 
(0-95) 
3 
(0-50) 
<0.001 
32 
(3-94) 
7 
(0-50) 
<0.001 
UDI- S 
(0-100) 
17 
(0-100) 
0 
(0-83) 
0.11 
17 
(0-100) 
17 
(0-83) 
0.33 
17 
(0-67) 
0 
(0-50) 
0.053 
UDI score 
(0-300) 
91 
(9-270) 
31 
(0-58) 
<0.001 
93 
(9-270) 
36 
(0-158) 
<0.001 
50 
(20-200) 
25 
(0-127) 
<0.001 
Numbers are median scores (range). Comparisons are made for all patients (overall), for patients with 
beneficial anatomical results at the 1 year follow up (Ba-1 cm or less) (n=72) as well as for patients with 
anatomical failure at the 1 year follow up (Ba 0 or more) (n=22). FU=Follow-up. UDI I= irritative subscale, 
O= obstructive subscale, S= stress subscale 
 
 
UDI in relation to primary or secondary procedures 
Of the 109 patient, 64 (59%) underwent surgery as a secondary procedure because of 
prolapse recurrence.  Tables 10 show the UDI subscales at baseline in 
relation/comparison to primary or recurrent prolapse status.  For primary procedures all 
three subscales of the UDI improved at 1 year follow-up.  For secondary procedures, 
the irritative and obstructive subscale improved whereas the stress scale was 
unchanged.   
 
When comparing the two groups, patients who had undergone a primary procedure had 
a lower overall UDI-score than those who had a secondary operation (p=0.03).   
Between groups comparisons further showed that primary cases had lower scores in the 
stress scale (p=0.049), whereas for symptoms in the irritative domain, scores were 
lower after having secondary procedure (p=0.009) (Table 10).  
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Table 10.  Comparison of lower urinary tract symptoms for: A) pre- and postoperative 
scores within groups, and B) pre- and postoperative scores between groups. 
 
A Primary procedure (n=45)  Recurrency (n=64)  
 Preoperatively 1 year 
follow-up 
P-value Preoperatively 1 year 
follow-up 
P-value 
UDI-I 36±28 29±15 <0.001 33±24 20±17 <0.001 
UDI-O 36±22 8±11 <0.001 35±21 11±13.5 <0.001 
UDI-S 22±27 13±20 0.02 22±21 23±24 0.856 
Overall 
UDI score 
91±64 35±37 <0.001 88±49 54±45 <0.001 
       
 Preoperatively  1 year follow-up  
B Primary 
procedure 
Recurrency P-value Primary 
procedure 
Recurrency P-value 
UDI-I 36±28 33±24 0.765 29±15 20±17 0.009 
UDI-O 36±22 35±21 0.750 8±11 11±13.5 0.59 
UDI-S 22±27 22±21 0.505 13±20 23±24 0.049 
Overall 
UDI score 
 
91±64 88±49 0.749 35±37 54±45 0.03 
Figures are mean± standard deviation.   
Subscale domains of the Urinary Distress Inventory: I= Irritative Symptoms; S= Stress 
Symptoms; O= Obstructive/Discomfort. 
 
 
   41 
 
8.2.4 Stress urinary incontinence 
Figure 14. Symptoms of stress urinary incontinence at baseline and one year after 
mesh surgery. 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
Figure 14 shows the change in stress urinary incontinence symptoms prior to surgery 
and at the one year follow-up. When we analyzed individual outcomes, the question 
“Urine leakage related to physical activity, coughing, or sneezing”, at baseline, 57/109 
patients (52%) reported any stress urinary incontinence.  Postoperatively, 18/57 patients 
(32%) reported complete resolution of stress urinary incontinence symptoms whereas 
32/57 patients (56%) reported aggravated stress incontinence.  A further nine patients 
reported de novo stress urinary incontinence, which combined with three patients 
having stress urinary incontinence surgery brings the rate of de novo stress symptoms 
to 11%. 
 52 no SUI 57 SUI 
18 complete 
resolution 
32 worse SUI 9 de novo 
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8.3 Paper III 
Of the 389 patients randomized and treated in the large RCT study, 302 (78%) were 
examined for lateral defects at baseline.  Of these patients, 99/302 (33%) were 
classified as having a lateral defect and 203/302 (67%) were classified as having no 
lateral defect.   
 
8.3.1 Subject characteristics  
The final study population available for analysis included 99 women having a lateral 
defect at baseline clinical examination.  Detailed descriptive data and statistical 
comparisons are presented in Table 11.  Women who underwent transvaginal mesh 
surgery had a higher BMI than in the colporraphy group, otherwise there were no other 
differences between the group regard to baseline characteristics.  
 
Table 11.  Characteristics of the study cohort. 
Characteristic Colporraphy 
 (n=39) 
Transvaginal mesh  
 (n=60) 
p-value 
Age at surgery (years) 64 (±9.4) 63.6 (±9.6) 0.71 
Body mass index (kg/m
2
) 25.0 (±3.0) 26.4 (±2.9) 0.01 
Number of childbirths
†
 2 (1-4) 2 (0-5) 0.20 
Cesarean deliveries 1 (2.6) 0 (0.0) 0.40 
Current smokers 2 (5.1) 11 (18.3) 0.06 
Age at menopause (years)  49.5 (±4.8) 50.2 (±4.8) 0.35 
Current use of hormone  29 (74.4) 36 (60.0) 0.14 
Previous pelvic surgery 13 (35.1) 23 (38.3) 0.75 
anterior repair 7 (18.9) 9 (15.0) 0.61 
posterior repair 5 (13.5) 8 (13.3) 1.0 
Hysterectomy 10 (27.0) 17 (28.3) 0.89 
Incontinence surgery 4 (10.8) 5 (8.3) 0.73 
UDI
‡
 91.5 ±52.4 89.6±47.5 0.93 
POP-Q stage     
II 15 (38.5) 25 (41.7) 0.75 
III 24 (61.5) 35 (58.3) 
Point Ba≥ 0 38 (97.4) 59 (98.3) 0.35 
Figures are number of patients (%).  Means ± SD.   
†Median with range. ‡ Responses to the Urogenital Distress Inventory (UDI), 
questionnaires combine to form overall scores which are presented as mean±SD. 
Comparison using Mann-Whitney U-test. Fischer’s exact or X² test was used for 
comparisons between proportions. 
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8.3.2 Anatomical outcomes 
One year after surgery, a persistent lateral defect was significantly more common after 
colporraphy (11/32 patients, 34.4%) compared to transvaginal mesh (1/42 patients, 
2.4%), (P<0.001) (Figure 15A).  This corresponded to a risk ratio of 14.4 (95% CI 2.0-
106.1).  Patients who were not examined for lateral defects at baseline or 
postoperatively did not differ from those who were examined in any significant way 
regarding to clinical characteristics. 
 One year after surgery, having an anatomic recurrence as defined by the POP-Q was 
also significantly more common in the colporraphy group (16/38 patients, 41.7%) 
compared to the transvaginal mesh group (4/58 patients, 6.9%) (P<0.001) (Figure 15B). 
In the colporraphy group, patients with no lateral defects had significantly less 
anatomic POP-Q failures at one year compared to patients with lateral defects, 19% vs 
73% (p= 0.006).  In the mesh group the small number of patients with both anatomical 
recurrence, as well as, persistent lateral defects, did not allow for a statistical 
comparison. 
 
Figure 15. 
Comparison between groups at 1-year follow up 
 
 
 
Figure A shows less lateral defects in the mesh group compared to the colporraphy 
group at the one year follow up.  
Figure B shows better anatomical outcome in the mesh group compared to the 
colporraphy group at the one year follow up. 
Figures are number of patients.  Comparison using Fischers exact test. 
 
8.3.3 Symptoms 
This analysis included the women who had answered the UDI questionnaire at entry 
and at one year follow up (n=75.)  Table 12 shows the UDI outcomes after colporraphy 
and transvaginal mesh.  There were no significant differences between the groups with 
regard to subjective symptoms neither according to the overall UDI score, nor the UDI 
subscales at one year follow-up.  However, patients in the colporraphy group with no 
lateral defects at follow up showed a significant improvement in the obstructive 
subscale (measuring the sensation of bulging and heaviness) compared to those with 
A B 
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persistent lateral defects (P= 0.03). In the mesh group only one patient had a persistent 
lateral defect one year after surgery, making comparisons impossible. 
 
Table 12. Urogenital Distress Inventory (UDI) after Colporraphy and Transvaginal 
mesh 
 Colporraphy 
Mean difference 
from baseline 
(n=32) 
Mesh 
Mean difference 
from baseline 
(n=43) 
p-value 
Total UDI 
 
37.3±50.6 39.0±45.8 0.61 
UDI-I 
 
12.1±19.9 11.2±18.5 0.91 
UDI-S 
 
4.3±28.2 1.5±24.1 0.65 
UDI-O 
 
20.4±16.1 22.9±19.5 0.33 
UDI scores and UDI subscales changes from preoperative to one year follow up 
assessments, shown for both groups. 
Comparison using Mann-Whitney U-test 
Mean difference ± standard deviation 
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8.4 Paper IV 
8.4.1 Subject characteristics 
Patients characteristics for women having no lateral defects (n=203) and patients with 
lateral defects (n=99) are presented in Table 13.  
 
Table 13. Subject demographics and clinical characteristics (n = 302) 
Demographics No lateral 
defect 
(n=203)  
 Lateral 
defects 
(n=99)  
 
 
 n % n % 
Age at surgery      
≤ 50 14 6.9 4 4 
51-70 132 65.0 70 70.7 
≥ 71 57 28.1 25 25.3 
Parity      
≤ 1 22 11 14 14.3 
≥ 2 178 89 84 85.7 
Body mass index (kg/m
2
)      
< 25 83 46.6 32 36.4 
25-30 73 41.0 47 53.4 
> 30 22 12.4 9 10.2 
Smokers 29 14.5 13 13 
Postmenopausal 182 89.8 92 93 
Hormone replacement therapy at baseline     
peroral 21 10.3 25 25.3 
local 83 40.9 40 40.4 
non 99 48.8 34 34.3 
Previous anterior vaginal wall repair 46 22.9 17 17.2 
Previous hysterectomy 45 22.3 30 30.3 
Previous posterior vaginal wall repair 22 10.8 13 13.1 
POP-Q      
stage II 85 42 40 40 
stage  III 118 58 59 60 
Data are n (%) 
 
8.4.2 Uni- and multivariable logistic regression model 
The uni- and multivariable analysis of clinical covariates associated with lateral defects 
included 174 patients with no lateral defect and 87 with lateral defects.  A number of 
factors were assessed in uni- and multivariable models to determine the association 
with lateral defects: age, parity, BMI, smoking, hormone replacement therapy (HRT), 
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POP-Q staging of the anterior vaginal wall, previous anterior wall repair, previous 
posterior wall repair and previous hysterectomy.  In the univariable analysis only oral 
HRT variable turned out to be significantly associated with lateral defects OR 3.5 (95% 
CI 1.7-7.0) (p<0.01).  In the final multivariable analysis all the variables included in the 
univariable analysis were considered. Oral use of HRT and previous anterior vaginal 
wall repair turned out to be significantly associated with lateral defects (OR 2.7, 95% 
CI 1.2-6.3 and OR 0.3, 95% CI 0.1-0.9 respectively). Previous anterior vaginal wall 
surgery decreased the odds for having a lateral defect in the multivariable analysis. Age 
and BMI were also included as continuous variables in the multivariable model and 
modeled partly as linear predictors and partly using restricted cubic splines as a 
sensitivity analysis in case the categorisation of these variables was non optimal.  
Neither variable showed any association with lateral defects in the models (p= 0.29; 
0.72 (linear model) and p= 0.05; 0.49 (spline model) for age and BMI respectively). 
The p-value from the Hosmer-Lemeshaw godness-of-fit test was 0.865 and the fit of 
the model can therefore be considered as acceptable.  No outliers were detected and the 
largest VIF value was 2.4 (for age), so multicollinearity was deemed low. There were 
no statistically significant interactions between any of the variables.  
 
8.4.3 Urinary Distress Inventory score 
There were no statistically significant differences between the two groups in any of the 
three UDI subscales (irritative, obstructive or stress) (p=0.78, p=0.60, p=0.77) (Figure 
16).  Only one question in the questionnaire showed a significant difference; “A feeling 
of bulging or protrusion in the vaginal area” was higher scored in the group with 
combined midline and lateral paravaginal defects (p=0.02). 
 
Figure 16. The three subscales of the Urinary Distress Inventory shown for patients 
with and without lateral defects.  
 
 
I=Irritative, O= Obstructive, S= Stress, There were no differences between the two 
groups in any of the three subscales (p=0.78, p=0.60, p=0.77). 
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Table 14. Uni- and multivariable analysis of clinical covariates 
association with lateral defects. 
 
Univariable Multivariable 
Odds 
ratio 
 
95% CI p-
value 
Odds 
ratio 
95% 
CI 
p-
value 
Age (years)   0.50   0.72 
≤ 50 0.7 0.2-2.2 0.49 0.6 0.1-4.4 0.59 
51-70 1.2 0.7-2.1 0.70 1.2 0.6-2.2 0.69 
≥ 71 Reference   Reference   
Parity      ≤ 1 Reference   Reference   
≥ 2 0.7 0.4-1.5 0.41 0.6 0.3-1.4 0.25 
BMI (kg/m
2
)   0.16   0.42 
< 25 Reference   Reference   
25-30 1.7 1.0-2.9 0.07 1.5 0.8-2.6 0.20 
> 30 1.1 0.4-2.6 0.89 1.1 0.4-2.7 0.90 
Smokers 0.9 0.4-1.8 0.75 0.9 0.4-1.9 0.70 
Postmenopausal 1.5 0.6-3.7 0.36 1.3 0.3-5.4 0.75 
Estrogen 
replacement 
therapy at baseline 
  <0.01   0.06 
non  Reference   Reference   
local 1.4 0.8-2.4 0.22 1.2 0.7-2.3 0.52 
peroral 3.5 1.7-7.0 <0.01 2.7 1.2-6.3 0.02 
Previous anterior 
vaginal wall repair 
0.7 0.4-1.3 0.25 0.3 0.1-0.9 0.02 
Previous posterior 
vaginal wall repair 
1.2 0.6-2.6 0.56 2.1 0.7-6.3 0.19 
Previous 
hysterectomy 
1.5 0.9-2.6 0.13 1.2 0.6-2.5 0.57 
POP-Q  stage II Reference   Reference   
     stage  III 1.0 0.6-1.7 0.87 1.0 0.6-1.7 0.92 
# Adjusted for all variables in Table 13.  
Analysis included 174 patients with no lateral defect and 87 with lateral defect. 
Note: BMI, body mass index; CI, confidence interval. 
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9 DISCUSSION 
9.1 Paper I 
In this randomized urodynamic study we found that trocar-guided transvaginal mesh 
repair of anterior vaginal wall prolapse is associated with a significant increase in 
objective de novo stress urinary incontinence compared to anterior colporraphy.  Stress 
urinary incontinence often co-exists with POP, particularly when the prolapse is mild.  
(40)  In contrast, women with advanced prolapse are less likely to have SUI (39) which 
can explain the low frequency of leakage at cough in our study population at baseline 
4/47 (8.5%)  where 38% of the women had stage III prolapse.  We used the ICS 
definition of urodynamic stress incontinence, with cough provocation during filling 
cystometry in the absence of detrusor contraction.  De novo leakage at cough 
provocation was observed in 2/25 (8%) women after colporraphy and 7/22 (32%) 
women after transvaginal mesh (P= 0.038).  Our findings corroborate a previous 
prospective clinical cohort study on the use of trocar-guided transvaginal mesh 
suggesting that even though most lower urinary tract symptoms decreased after 
surgery, stress urinary incontinence did not. (92)  In a published retrospective study of 
sixty patients who underwent total vaginal mesh repair without midurethral sling after 
negative preoperative urodynamics, fifteen (25%) patients were diagnosed with de 
novo stress urinary incontinence. (118)  These findings are consistent with another 
retrospective study of 309 patients by Aungst et al. (109) in which the rate of de novo 
stress incontinence after transvaginal mesh repair was 24.3%. 
 
The cause of de novo SUI after prolapse correction is not fully understood.  It is 
thought that correcting the prolapse eliminates the dynamic obstruction of the urethra 
and therefore allows for stress related urine leakage.  It is possible that the effective 
suspension of the anterior vaginal wall and bladder neck during trocar-guided 
transvaginal mesh surgery affects urethral support and urethral closure to a greater 
extent than colporraphy i.e. over-corrects the urethra and bladder neck.  The mesh may 
also deflect the urethrovesical junction posteriorly as a result of excessive tensioning or 
contraction of the mesh postoperatively.  It could also be explained by mesh techniques 
causing greater and wider perioperative dissection causing instability to the suburethral 
layer or injury to the urthral innervation.  The effectiveness of the urethral compression 
mechanism is dependant of the layer formed by the connection of the endopelvic fascia 
and anterior vaginal wall to the arcus tendineus fascia pelvis (46) and the mesh may 
affect the stability of the suburethral layer and mobility of the urethra. 
 
The MUCP, defined during urethral pressure profiling, represents the highest pressure 
along the functional length of the urethra.  In our study, MUCP decreased in both 
groups after surgery but the decrease was more pronounced in the mesh group.  In the 
mesh group, MUCP was lower postoperatively compared to baseline (44 to 26, p=0.07) 
and the distribution of MUCP (in quartiles) (p=0.008) tended to move to lower values.  
The MUCP has been reported to correlate with stress incontinence severity and with 
surgical outcomes in some studies, but not in others, and the reproducibility of urethral 
pressure profile parameters is poor. (119)  Some studies have found no difference in 
average MUCP in women with and without SUI, whereas other studies have found that 
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urethral pressures are lower in women with SUI. (119)  Thus the predictive value is 
doubtful and urethral pressure profiling cannot be used as a diagnostic test for SUI in a 
clinical setting.  
 
In our study population, only two patients had detrusor contractions during bladder 
filling preoperatively.  Some studies suggest that the sensitivity of clinical diagnosis is 
better than that obtained with urodynamic testing, because more than 50% of patients 
with subjective urge urinary incontinence have normal urodynamic studies and that 
detrusor overactivity may be observed on cystometry in about 10% of asymptomatic 
women. (120) We neither observed increased postvoidal residual urine volumes, nor 
decreased urine flow velocities, within the treatment groups before and after surgery, or 
when comparing the two groups postoperatively.  Although this in agreement with 
previous reports based on self-reported outcomes, (92) a supposed change of the 
urethral and bladder neck angulation would be expected to give rise to adverse changes 
also in urodynamic variables associated with bladder emptying.  On a similar note, we 
found no indications of reduced cystometric bladder capacity, decreased bladder 
sensitivity, or an increase in detrusor contractions during bladder filling.   
 
Evidence of leakage during cough in the absence of a detrusor contraction was recorded 
as urodynamic evidence of SUI.  Several studies have demonstrated that when stress 
incontinence is the only symptom, urodynamic stress incontinence is likely to be 
present in 90% of cases but the relationship between urge incontinence and detrusor 
overactivity is less evident. (121, 122)  Though the positive predictive value of 
urodynamic testing for SUI the sensitivity is moderate at best. (121, 122) 
 
9.2 Paper II 
We found that anterior vaginal wall prolapse surgery using a trocar guided transvaginal 
mesh kit resulted in significant improvements of self-reported obstructive and irritative 
lower urinary tract symptoms.   In concurrence with previous reports, transvaginal 
mesh repair of the anterior vaginal wall did not result in overall improvement of stress 
urinary incontinence. (90, 123-125)  We used the ICS definition of symptoms of stress 
urinary incontinence, which is based on two validated questions in the UDI. (126)  De 
novo stress urinary incontinence occurred in 12/109 (11%) and 32/57 (56%) reported 
worsening SUI.  However at baseline only 52 of the 109 patients did not have any 
symptoms of SUI, whereas 57 patients did.  Hence, of the patients at risk 23% (12/52) 
reported de novo SUI.  Comparing our results with the Cochrane review of surgical 
management of prolapse, (53) our study population showed higher rates of de novo SUI 
(23% vs 15%) which could possibly be explained by the significant heterogeneity when 
the data from all the trials were combined in a meta-analysis. 
 
Comparing six newly published randomised controlled trials on transvaginal mesh vs. 
traditional surgery for repair of the anterior vaginal wall, the frequency of de novo SUI 
after mesh repair ranged between 0-12%. (90, 91, 95-97, 127)  However in two trials 
the frequency of concomitant mid-urethral sling was 49-70%. (91, 95) and in two trials 
the frequency of de novo SUI was not reported. (91, 95)  In three out of six of the RCT: 
s, concomitant vaginal hysterectomy was performed in 30-60%. (91, 95, 96)  These 
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differences make it difficult to compare the effect on SUI, which was a secondary 
outcome in all six studies.  
 
Although overactive bladder symptoms should be considered an important adverse 
outcome after prolapse surgery but the occurrence of this symptom complex is rarely 
reported separately.  The effect of urge urinary incontinence and prolapse surgery is 
limited and inconclusive. (53)  In concordance with the literature we found an 
improvement of irritative symptoms such as frequent urination, urgency, nocturia and 
urge incontinence after trocar guided mesh surgery. (90, 125, 128)  Resolution of 
symptoms in the irritative and the obstructive domains were present regardless of 
anatomical outcomes.  Although the procedure improved irritative symptoms in both 
recurrent and primary prolapse cases (p<0.001), the relief of irritative symptoms were 
more pronounced in the group of patients having the procedure for recurrent prolapse 
(p=0.009).  The reason for this observation is not clear and deserves further 
investigation.   
 
In this study, 44% (25/57) of preoperatively stress incontinent women reported cure or 
improvement of their stress incontinence at the one year follow-up.  As the 
transobturator mesh behaves like an oversized trigonal sling, it may similarly exert 
some limited compressive effect on the urethra and may contribute to improvement of 
stress urinary incontinence.  A retrospective cohort study with transobturator mesh 
repair in women with cystocele showed that a narrower distance between the 
symphysis pubis and mesh on ultrasound was associated with improvement or cure of 
SUI.(129) 
 
The present study adds to the growing body of evidence suggesting that prolapse 
surgery using trocar guided transvaginal mesh kits is associated with postoperative 
stress urinary incontinence.  It has been hypothesised that the overall effective anterior 
vaginal wall and bladder neck suspension after trocar guided transvaginal mesh surgery 
increases the risk for postoperative stress urinary incontinence by distorting urethral 
pressure dynamics. (92, 130, 131)  Indirect evidence to support this notion was 
provided by patients with point Ba inside the hymen after surgery.  In this group of 
patients there was no significant change in stress related symptoms postoperatively.  
However, in women with point Ba at the hymen or beyond, improvements in stress 
urinary incontinence symptoms were seen postoperatively, albeit with borderline 
significance (p=0.05).  This suggests that an effective elevation, or straightening, of the 
anterior vaginal wall and bladder neck may introduce a risk for stress urinary 
incontinence after transvaginal mesh surgery using a trocar guided transobturator 
approach. 
In the present study we used the hymen to discriminate symptoms in relation to the 
anatomical outcome.  Previous epidemiological investigations indicate that the hymen 
(0-plane) is an important “cut-off” level with regard to symptoms.  Several studies have 
shown that women with prolapse beyond the hymen have more pelvic floor symptoms 
and are more likely to report a vaginal bulge than women with prolapse above the 
hymen. (12, 20, 37, 132, 133)  
 
Strengths of this study include the prospective data collection, the multicenter study 
design, and the use of a standardised surgical technique using a single identical mesh 
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kit throughout all participating centres.  The few concomitant surgical procedures add 
to the internal validity of our study.  Among the limitations of the study we 
acknowledge that the lack of objective measures of lower urinary tract function and an 
independent control group could have provided relevant information on lower urinary 
tract function in relation to transvaginal mesh surgery. 
 
By using the full range of the UDI and its subscales, we could show that trocar guided 
transvaginal mesh repair of anterior vaginal wall prolapse not only was associated with 
negative, but also positive effects with regard to both obstructive and irritative lower 
urinary tract symptoms.  We can only speculate on the mechanisms responsible for 
irritative symptom relief after surgery but these effects are plausibly related to the 
concurrent resolution of obstructive symptoms where we observed the proportionally 
greatest improvements.  The effect on urge urinary incontinence symptoms after 
prolapse surgery is limited and inconclusive. (53)  Both improvement in overactive 
bladder symptoms (134, 135)and no changes have been reported. (136)  The integral 
theory by Papa Petros and Ulmsten hypothesized that stress and urge symptoms both 
derive, for different reasons, from anatomic laxity of the anterior vaginal wall.  
(137)The laxity may be caused by defects in the vaginal wall itself or in the ligaments 
and muscles that support it.  According to this theory, the vaginal wall has a structural 
function that prevents urgency by supporting hypothesized stretch receptors located in 
the proximal urethra and bladder neck. (137)  It is feasible that overactive bladder 
symptoms are to some extent a result of bladder outlet obstruction in women with 
anterior vaginal wall prolapse.  Altered properties of the detrusor myocytes as a result 
of bladder emptying difficulties caused by loss of support to the bladder, may give rise 
to increased excitability and activity of the detrusor muscle. (138)  As a consequence, 
overactive bladder symptoms may decrease in parallel with improved bladder emptying 
following the successful restoration of anterior vaginal wall and bladder support.   
 
9.3 Paper III 
In this study, use of a trocar guided transvaginal mesh kit for anterior vaginal wall 
prolapse repair resulted in significantly improved anatomical outcomes with regard to 
lateral defects compared to anterior colporraphy.  This is hardly surprising and can 
easily be explained since the mesh covers and supports the central and lateral anterior 
vaginal wall in contrast to anterior colporraphy where the midline plication only 
corrects a midline defect.  For this reason it is interesting to note that although the 
anatomical results of colporraphy were inferior to the mesh group, patients in the 
colporraphy group nonetheless had successful correction of lateral defects in two thirds 
of the cases.  The reason for this cannot be attributed to the effects of other procedures 
because no concurrent surgery was permitted at the time of study treatment.  Perhaps 
anterior colporraphy, by reducing the surface area of the exposed vagina, brings the 
anterior wall back into contact with the posterior vaginal wall and reduces the tension at 
the ATFP junction. (47)  Another possibility is that the scar tissue developed after 
anterior colporraphy with midline plication of the pubocervical fascia lessens the 
tension and thus resolves and masks the lateral defect. 
 
In 1909 George R. White described a method of cystocele repair that consisted of 
“suturing the lateral sulci of the vagina to the white line of pelvic fascia” through a 
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vaginal approach. He was the first to describe lateral (paravaginal) defect as a cause for 
anterior vaginal wall prolapse. (139)  In 1976 Richardson et al. reintroduced the lateral 
defect repair but described a technique of repair with an abdominal approach. (140) 
They characterized anterior wall prolapse as: lateral defects; transverse defects where 
the anterior vaginal wall became detached from the cervix; and midline defects where 
the vaginal wall itself failed.  On the basis of a large series of surgical patients they 
concluded that most cystoceles resulted from a detachment of the pubocervical fascia at 
or near its lateral attachment to the ATFP. (140, 141)  Although this anatomical defect 
is well described in the literature, the prevalence among women with anterior wall 
prolapse varies greatly (ranging from 37% to 88%) and the ability to diagnose these 
defects both pre- and intraoperative is uncertain. (47, 141-143)  The prevalence of 
lateral defects among the examined patients in our study was in the lower range of what 
previously has been described (33%).  Previous studies assessing the occurrence of 
lateral defects were, however, mainly designed and focused on determining the 
prevalence of lateral defects in a given population, which might have yielded a higher 
detection rate as compared to our study, where the diagnosis of a lateral defect was a 
secondary outcome measure.  Also, differences in diagnostic criteria and methods 
between our study and previous works may contribute to the rather large discrepancy in 
prevalence estimates.  
 
There is a strong association between apical descent and cystocele and the loss of apical 
support may contribute to the development of lateral defects. (144)  In the main trial the 
preoperative median position of the apical segment (POP-Q point C) was within the 
normal range and the study population both in the main trial and this subanalysis 
therefore represents women that have a cystocele but no clinically significant apical 
descent. (90)  In a retrospective chart review performed by Barber et al., the 
investigators reported good sensitivity and negative predictive values, but poor 
specificity and positive predictive values when comparing surgical findings with the 
preoperative clinical assessment of lateral defects (141)  Dietz et al. found poor 
correlations between clinical examination and ultrasound imaging of lateral defects and 
concluded that lateral defects may be uncommon or clinically irrelevant. (145)  On the 
other hand, De Lancey et al. found convincing support for the notion that lateral defects 
indeed exist when comparing women with anterior prolapse and women with normal 
vaginal topography at pelvic MRI.  The study showed that the lateral vagina is 
displaced from its normal position in women with anterior prolapse (lateral defects) and 
was greater than changes in vaginal width (central defects) indicating that there are 
changes in both regions of the vagina. (146) 
 
Subjective outcomes in the context of surgical repair of lateral defects are poorly 
investigated and described.  We found that despite the large difference between the 
treatment groups with regard to anatomical outcomes, both at the midline and laterally, 
there were no significant differences between the treatment groups neither with regard 
to the overall UDI nor any of the UDI subscales.  In agreement with Morse et al. (147) 
our data suggest that restoration of support at the ATFP junction does not necessarily 
reflect improved subjective outcomes.  On the other hand we found that among patients 
in the colporraphy group with persistent lateral defects at the one year follow-up, only 
obstructive symptoms decreased significantly upon successful repair of the lateral 
defect.  When we compared patients with anatomical failures (point Ba≥0) with non-
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failures in the colporraphy group, the subscales of the UDI did not differ significantly.  
Although this study population was relatively small, our findings indicate that a 
persistent lateral defect to a greater extent influence obstructive symptoms as compared 
to a persistent midline weakness. 
 
Strengths of our study include the standardized and uniform surgical procedures, use of 
condition specific symptom questionnaires and the POP-Q.  The clinical definition we 
used to define lateral defects is not part of the POP-Q system, which does not include 
any measurement point for lateral defects, but at present there is no clinically validated 
method to determine if a lateral defect is present or not. (148)  Another limitation is that 
only 78% of the randomized patients in the study were examined for lateral defects, 
which to some extent may be a result of selection or ascertainment bias.  However, 
patients who were not examined for lateral defects at baseline or postoperatively did 
not differ from those who were examined in any significant way regarding other 
clinical characteristics, suggesting that the magnitude of this potential source of bias 
was limited. 
  
9.4 Paper IV 
Variables significantly associated with the presence of a lateral defect included 
previous anterior prolapse repair and HRT use.  An association between HRT and gross 
anatomical changes such as lateral defects has not been studied previously although a 
theoretical link between HRT and collagen degradation has been described. (149) 
Furthermore, HRT has been shown to actually increase the risk for urinary incontinence 
in a placebo controlled RCT. (150)  Thus, current evidence suggest that HRT may 
influence pelvic floor connective tissue resilience and support.  The reason for HRT use 
being of particular importance for the development of lateral defects in specific remains 
elusive.  However, one may speculate that the vaginal ATFP junction for some reason 
may be more sensitive to hormonal effects on collagen degradation or may increase 
loose connective tissue. (149)  These findings should be interpreted with caution since 
we were unable to categorise hormone use further and as such our data should be 
considered as a hypothesis generating finding which is in need of corroboration and 
further studies. 
 
The association between lateral defects and previous anterior prolapse repair may be an 
effect of the scar tissue developed after anterior colporraphy with midline plication of 
the pubocervical fascia lessens the tension and thus resolves and masks the lateral 
defect which is consistent with our previous findings in paper III and this has recently 
been discussed in the literature. (146)  In the univariable regression model this was not 
significant but in the adjusted model previous anterior vaginal wall surgery decreased 
the odds for having a lateral defect.  Considering that this factor was non-significant in 
univariable analysis, and the relatively small number of cases, care should be taken not 
to overstate conclusions from this finding because of limited statistical precision.  None 
of the other variables included in the risk analysis showed any association with the 
diagnosis of a lateral defect.  Richardson et al reported that lateral defects usually 
results in mild cystocele (140) which is in contrast with our and others findings 
showing no association between stage of prolapse and lateral defects. (143) 
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One of the main drawbacks of the present study involves classification of lateral 
defects.  There were many physicians performing the clinical examinations, each with 
different experience of diagnosing lateral defects.  Presumably it takes experience 
before becoming proficient in detecting a lateral defect, and the level of training may 
have influenced our detection rate.  Thus classification bias may to some extent have 
affected our results and there is evidence suggesting that the clinical examination of 
anterior vaginal wall support defects displays poor inter- and intra-examiner agreement. 
(141)  Also, there is no uniform clinical classification system or examination technique 
used to describe lateral defects. 
 
With regard to subjective outcomes, patients with lateral defects were primarily 
characterized by an increased sensation of vaginal bulging when compared to patients 
with isolated central defects.  No other symptoms were more commonly prevalent in 
the group of patients with lateral defects compared to those with a central defect only. 
This suggests that screening of patients using symptom surveys may not be a useful 
tool for the differentiation between central defects with or without concurrent lateral 
defects.   
Current knowledge on the presentation and clinical characteristics of patients with 
lateral defects is rare.  Our analysis also provides an opportunity for future prospective 
evaluations on how symptoms progress over time in relation to the occurrence and 
treatment of lateral defects.  
 
It is widely assumed that obstetrical injury to pelvic floor supportive tissue structures is 
the most important risk factor for anterior vaginal wall prolapse. (23, 24)  We recognize 
that it would have been of interest if more detailed information on obstetric events were 
included in the present analysis.  Factors such as forceps delivery, external pressure and 
prolonged duration of labour may be relevant for the presentation of lateral defects 
when compared to patients only presenting with a central defect. (24, 151)  Given that 
the number of childbirths did not differ between patients with a central and those with a 
lateral defect it is likely that the importance of obstetric event for the development of 
lateral defects needs further dissection to provide meaningful result. 
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10 CONCLUSIONS 
The specific aims are repeated with the conclusions for the convenience of the reader: 
 
Aim: To investigate the urodynamic effects of anterior vaginal wall prolapse 
surgery using either trocar guided transvaginal mesh or colporraphy. (Paper I) 
 
Conclusion: Use of a standardized trocar-guided transvaginal mesh kit for anterior 
vaginal wall prolapse repair was associated with more pronounced adverse effects 
on maximal urethral closing pressure and a significantly increased number of 
women with de novo stress urinary incontinence when compared to anterior 
colporraphy.  
 
Aim: To assess the effects of trocar guided transvaginal mesh on lower urinary 
tract symptoms after anterior vaginal wall prolapse repair. (Paper II) 
 
Conclusion: Use of a trocar guided transvaginal mesh kit for anterior vaginal wall 
prolapse repair was associated with an overall resolution of most symptoms 
associated with urge urinary incontinence and bladder outlet obstruction.  These 
beneficial effects should be weighed against the increased risk for stress urinary 
incontinence related to the procedure. 
 
Aim: To evaluate objective and subjective outcomes following the use of 
transvaginal mesh compared with traditional colporraphy for repair of anterior 
vaginal wall lateral defects. (Paper III) 
 
Conclusion: Trocar guided transvaginal mesh kit significantly improved the odds 
for restoration of lateral vaginal support and vaginal topography in patients with 
lateral defects as compared to traditional anterior colporraphy.  However, this did 
not result in significant differences in patient reported outcomes after one year. 
 
Aim: To compare clinical characteristics and symptoms among patients with 
isolated central defects and patients with a combination of both central and lateral 
defects. (Paper IV) 
 
Conclusion: Clinical patient characteristics has a limited role in the occurrence of 
lateral defects among patients with anterior vaginal wall prolapse and most 
subjective symptoms are shared with isolated central anterior vaginal wall prolapse.  
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11 POPULÄRVETENSKAPLIG SAMMANFATTNING 
Svaghet i bäckenbotten i form av framfall medför att slidans väggar buktar eller att 
livmodern faller ner och kan ge olika symtom hos kvinnor. Det vanligaste symtomet, 
och som oftast är orsaken till att kvinnan söker sjukvård, är känslan av att något faller 
fram i slidan (globuskänsla).  Efter vaginal förlossning uppvisar nära hälften av alla 
kvinnor anatomiska fynd på grund av bristande stöd för slidväggarna.  Alla dessa 
kvinnor har dock inte symtom.  Riskfaktorer för bäckenbottensvaghet anses vara: 
många graviditeter, svåra förlossningar, ökad ålder och övervikt.  Framfallsoperationer 
tillhör en av de vanligaste gynekologiska operationerna och det utförs ca 8000 
operationer i Sverige varje år.  Ett ökat sjukvårdsbehov kan väntas när kvinnor blir allt 
äldre.  Någon säkerställd profylax finns inte.  
 
De operationsmetoder som använts i över hundra år har i studier visats sig ge stor risk 
för återfall och är sparsamt utvärderade.  Otillfredsställande resultat efter operation är 
vanliga.  Vid traditionell kirurgi av framfall försöker man återskapa anatomin genom 
att förstärka den skadade vävnaden med olika suturer.  Uppskattningsvis får var tredje 
kvinna som opereras ett återfall.  Operationsmetoder med användande av syntetiska nät 
har under de senaste åren prövats med varierande resultat.  Vid ljumskbråckskirurgi och 
urininkontinenskirurgi har man uppnått goda operationsresultat vid användning av 
syntetiska polypropylennät som stöd för den sviktande vävnaden och till följd av detta 
sker en ökad användning av syntetiska implantat även vid framfallskirurgi. 
Användandet ökar nu snabbt baserat på rapporter om förbättrade resultat och färre 
återfall.  Dock förefaller de nya metoderna medföra ökad risk för komplikationer och 
långtidsresultat saknas.  Det är därför viktigt att fortsatt utvärdera dessa metoder.  
Denna avhandling avser belysa kliniska aspekter, såväl anatomiska som subjektiva 
utfall vid framfallsoperationer av främre vaginalväggen med syntetiska nät. 
 
I den första studien har fem kliniker i Sverige och Danmark samarbetat i en 
randomiserad kontrollerad studie. 52 kvinnor med framfall i främre vaginalväggen 
lottades till traditionell kirurgi eller operation med ett syntetiskt nät.  Nätet placerades 
med hjälp av metalledare för att åtgärda framfallet.  De undersöktes gynekologiskt och 
fick fylla i enkäter angående symtom av framfall och urinbesvär före operationen och 2 
månader efter.  Patienterna fick även genomgå urodynamisk undersökning som avser 
utreda funktionen av urinblåsan och urinröret.  Vi fann en ökad förekomst av ofrivilligt 
urinläckage i samband med hostprovokation hos patienterna som opererats med nät 
jämfört med de kvinnor som opererats med traditionell metod.  
 
I den andra studien har flera kliniker i de nordiska länderna samarbetat i en prospektiv 
kohortstudie.  109 kvinnor med framfall i framväggen inkluderades och genomgick 
operation med ett syntetiskt nät.  Ett validerat frågeformulär med 19 frågor om 
framfallsrelaterade besvär fylldes i före operation och efter ett år.  Uppgivna symtom 
från urinblåsan och urinröret såsom urinträngningar, trängningsinkontinens och 
blåstömningsbesvär förbättrades.  Känslan av att något buktar ut ur slidan 
(globuskänsla), tyngdkänsla och smärta i bäckenet förbättrades också efter operationen. 
Kvinnorna förbättrades dock inte beträffande symtom som rörde 
ansträngningsinkontinens och 11% fick nytillkommen ansträngningsinkontinens.  
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I den tredje studien har vi ur en stor, randomiserad multicenterstudie utvärderat två 
olika operationsmetoders effekt på de anatomiska strukturerna i vaginas framvägg och 
symtom.   99 patienter med s.k. laterala defekter inkluderades och vi fann att 
nätoperation i framväggen korrigerade laterala defekterna i signifikant högre 
utsträckning än traditionell kirurgi ett år efter operation.  Vid traditionell kirurgi 
korrigerar man bara defekter i medellinjen medan man vid nätoperationen täcker hela 
främre vaginalväggen.  Trots detta fann vi ingen skillnad i symtom mellan grupperna.  
 
Den fjärde studien är en tvärsnittsstudie och använder sig av samma patientgrupp som 
den stora randomiserade multicenterstudien och fokuserar på att jämföra faktorer som 
kan tänkas påverka/ha betydelse för lateral defekt. 203 kvinnor utan lateral defekt 
jämfördes med 99 kvinnor med lateral defekt avseende kliniska karakteristika och vi 
fann att användandet av hormoner i samband med klimakteriet ökade risken för lateral 
defekt och kvinnor som tidigare i livet genomgått framfallsoperation av framväggen 
hade lägre risk för att ha lateral defekt. 
 
I denna avhandling har vi funnit att standardiserade framfallsoperationer med nät kan 
genomföras med tillfredställande subjektiva och anatomiska resultat.  Det föreligger 
dock en ökad risk för besvär med ansträngningsinkontinens efter operationen.  I 
jämförelse med den traditionella kirurgin är operationer med syntetiska nät fortfarande 
en ny metod där potentiella risker och vinster, framförallt på lång sikt, måste övervägas. 
 
 58 
12 ACKNOWLEDGEMENTS 
In particular I would like to thank: 
 
The patients who took part in the studies. 
 
The Nordic Transvaginal Mesh Group doctors who performed all surgeries. 
 
Gunilla Tegerstedt, my principal tutor, clinical supervisor and friend. Thank you for 
your generous support, for your warmth and sharing your scientific knowledge in 
surgical techniques. Your enthusiasm for clinical research spread to all and was the 
reason I started doing research. 
  
Daniel Altman, my co-tutor, for excellent scientific guidance during these years. 
Thank you for invaluable help with writing and for coaching me throughout the project, 
for your generosity and friendship. 
 
Margareta Hammarström, my co-tutor and head of the Department of Obstetrics and 
Gynecology at Södersjuhuset. Thank you for all support warmth and being there for me 
when I needed it. 
 
Tekla Lind, my collegue and dear friend, for your hourly sms updates and for all 
exciting discussions about life and love and for your wonderful sense of humor. 
 
Lina Benson, thank you for excellent teaching of statistics in paper III and IV. 
 
Marie Söderberg Westergren, for support and development in prolapse surgery, 
constant discussion of urogynecology and teaching me surgical skills. 
  
Mats Bergström, head of Gynecology at Södersjukhuset. Thank you for your support 
and organizing a great planning day in Stockholm archipelago. 
 
Inger Nordlander, urotherapist at Södersjukhuset, for your professionalism and for 
teaching me. 
 
To all amazing colleagues at the Department of Obstetrics and Gynecology at 
Södersjuhuset, especially Tekla Lind, Anna Kyndel, Petra Bygdevall, Lotta 
Herling, Katarina Westman, Charlotta Ersmark and Eva Enocson  for a wonderful 
trip to London after my half-time control. 
 
Caroline Elmer for giving me good advice, for your friendship and support 
 
My mother Ingrid Ek and my sisters Maria Ek-Oldsjö and Judit Ek for love and 
loyality.  
 
   59 
My close friends Malin Brilioth, Cecilia Broman, Emma Dahlbäck, Elsa Janni, 
Elsa Håstad, Maria Mårtensson and Lina Pleijel for incredibly enthusiastic and 
encouraging. 
  
To Stefan, my husband, my great love in life and our three wonderful children, Jens, 
Sofia and Benjamin. 
 60 
13 REFERENCES 
 
1. Jelovsek, J.E., C. Maher, and M.D. Barber, Pelvic organ prolapse. Lancet, 
2007. 369(9566): p. 1027-38. 
2. Jelovsek, J.E. and M.D. Barber, Women seeking treatment for advanced pelvic 
organ prolapse have decreased body image and quality of life. Am J Obstet 
Gynecol, 2006. 194(5): p. 1455-61. 
3. Miedel, A., et al., Symptoms and pelvic support defects in specific 
compartments. Obstet Gynecol, 2008. 112(4): p. 851-8. 
4. Sand, P.K., et al., Prospective randomized trial of polyglactin 910 mesh to 
prevent recurrence of cystoceles and rectoceles. Am J Obstet Gynecol, 2001. 
184(7): p. 1357-62; discussion 1362-4. 
5. Weber, A.M., et al., Anterior colporrhaphy: a randomized trial of three 
surgical techniques. Am J Obstet Gynecol, 2001. 185(6): p. 1299-304;. 
6. Ashton-Miller, J.A. and J.O. DeLancey, Functional anatomy of the female 
pelvic floor. Ann N Y Acad Sci, 2007. 1101: p. 266-96. 
7. Heesakkers, J.P. and R.R. Gerretsen, Urinary incontinence: sphincter 
functioning from a urological perspective. Digestion, 2004. 69(2): p. 93-101. 
8. Delancey, J.O., Why do women have stress urinary incontinence? Neurourol 
Urodyn, 2010. 29 1: p. S13-7. 
9. DeLancey, J.O., Anatomic aspects of vaginal eversion after hysterectomy. Am J 
Obstet Gynecol, 1992. 166(6 Pt 1): p. 1717-28. 
10. Whinters, C., in ICS. 2011. 
11. Tegerstedt, G., et al., Prevalence of symptomatic pelvic organ prolapse in a 
Swedish population. Int Urogynecol J Pelvic Floor Dysfunct, 2005. 16(6): p. 
497-503. 
12. Swift, S., et al., Pelvic Organ Support Study (POSST): the distribution, clinical 
definition, and epidemiologic condition of pelvic organ support defects. Am J 
Obstet Gynecol, 2005. 192(3): p. 795-806. 
13. Samuelsson, E.C., et al., Signs of genital prolapse in a Swedish population of 
women 20 to 59 years of age and possible related factors. Am J Obstet 
Gynecol, 1999. 180(2 Pt 1): p. 299-305. 
14. Uustal Fornell, E., G. Wingren, and P. Kjolhede, Factors associated with pelvic 
floor dysfunction with emphasis on urinary and fecal incontinence and genital 
prolapse: an epidemiological study. Acta Obstet Gynecol Scand, 2004. 83(4): 
p. 383-9. 
15. Olsen, A.L., et al., Epidemiology of surgically managed pelvic organ prolapse 
and urinary incontinence. Obstet Gynecol, 1997. 89(4): p. 501-6. 
16. Brown, J.S., et al., Pelvic organ prolapse surgery in the United States, 1997. 
Am J Obstet Gynecol, 2002. 186(4): p. 712-6. 
17. Clark, A.L., et al., Epidemiologic evaluation of reoperation for surgically 
treated pelvic organ prolapse and urinary incontinence. Am J Obstet Gynecol, 
2003. 189(5): p. 1261-7. 
18. Miedel, A., et al., A 5-year prospective follow-up study of vaginal surgery for 
pelvic organ prolapse. Int Urogynecol J Pelvic Floor Dysfunct, 2008. 19(12): p. 
1593-601. 
19. Dietz, H.P., The aetiology of prolapse. Int Urogynecol J Pelvic Floor Dysfunct, 
2008. 19(10): p. 1323-9. 
20. Miedel, A., et al., Nonobstetric risk factors for symptomatic pelvic organ 
prolapse. Obstet Gynecol, 2009. 113(5): p. 1089-97. 
   61 
21. Mant, J., R. Painter, and M. Vessey, Epidemiology of genital prolapse: 
observations from the Oxford Family Planning Association Study. Br J Obstet 
Gynaecol, 1997. 104(5): p. 579-85. 
22. Rortveit, G., et al., Age- and type-dependent effects of parity on urinary 
incontinence: the Norwegian EPINCONT study. Obstet Gynecol, 2001. 98(6): 
p. 1004-10. 
23. Tegerstedt, G., et al., Obstetric risk factors for symptomatic prolapse: a 
population-based approach. Am J Obstet Gynecol, 2006. 194(1): p. 75-81. 
24. DeLancey, J.O., et al., The appearance of levator ani muscle abnormalities in 
magnetic resonance images after vaginal delivery. Obstet Gynecol, 2003. 
101(1): p. 46-53. 
25. Dietz, H.P. and V. Lanzarone, Levator trauma after vaginal delivery. Obstet 
Gynecol, 2005. 106(4): p. 707-12. 
26. DeLancey, J.O., et al., Vaginal birth and de novo stress incontinence: relative 
contributions of urethral dysfunction and mobility. Obstet Gynecol, 2007. 110(2 
Pt 1): p. 354-62. 
27. DeLancey, J.O., et al., Comparison of levator ani muscle defects and function in 
women with and without pelvic organ prolapse. Obstet Gynecol, 2007. 109(2 Pt 
1): p. 295-302. 
28. Hoyte, L., et al., Two- and 3-dimensional MRI comparison of levator ani 
structure, volume, and integrity in women with stress incontinence and 
prolapse. Am J Obstet Gynecol, 2001. 185(1): p. 11-9. 
29. Jorgensen, S., H.O. Hein, and F. Gyntelberg, Heavy lifting at work and risk of 
genital prolapse and herniated lumbar disc in assistant nurses. Occup Med  
1994. 44(1): p. 47-9. 
30. Spence-Jones, C., et al., Bowel dysfunction: a pathogenic factor in uterovaginal 
prolapse and urinary stress incontinence. Br J Obstet Gynaecol, 1994. 101(2): 
p. 147-52. 
31. Altman, D., et al., Genetic influence on stress urinary incontinence and pelvic 
organ prolapse. Eur Urol, 2008. 54(4): p. 918-22. 
32. Forsgren, C., et al., Risk factors for vaginal vault prolapse surgery in 
postmenopausal hysterectomized women. Menopause, 2008. 15(6): p. 1115-9. 
33. Chen, B.H., et al., Collagen metabolism and turnover in women with stress 
urinary incontinence and pelvic prolapse. Int Urogynecol J Pelvic Floor 
Dysfunct, 2002. 13(2): p. 80-7 
34. Soderberg, M.W., et al., Young women with genital prolapse have a low 
collagen concentration. Acta Obstet Gynecol Scand, 2004. 83(12): p. 1193-8. 
35. Ellerkmann, R.M., et al., Correlation of symptoms with location and severity of 
pelvic organ prolapse. Am J Obstet Gynecol, 2001. 185(6): p. 1332-7;  
36. Tegerstedt, G., et al., A short-form questionnaire identified genital organ 
prolapse. J Clin Epidemiol, 2005. 58(1): p. 41-6. 
37. Swift, S.E., S.B. Tate, and J. Nicholas, Correlation of symptoms with degree of 
pelvic organ support in a general population of women: what is pelvic organ 
prolapse? Am J Obstet Gynecol, 2003. 189(2): p. 372-7; 
38. Barber, M.D., et al., Defining success after surgery for pelvic organ prolapse. 
Obstet Gynecol, 2009. 114(3): p. 600-9. 
39. Burrows, L.J., et al., Pelvic symptoms in women with pelvic organ prolapse. 
Obstet Gynecol, 2004. 104(5 Pt 1): p. 982-8. 
40. Barber, M.D., Symptoms and outcome measures of pelvic organ prolapse. Clin 
Obstet Gynecol, 2005. 48(3): p. 648-61. 
 62 
41. Abrams, P., et al., The standardisation of terminology of lower urinary tract 
function: report from the Standardisation Sub-committee of the International 
Continence Society. Neurourol Urodyn, 2002. 21(2): p. 167-78. 
42. Serati, M., et al., Urinary symptoms and urodynamic findings in women with 
pelvic organ prolapse: is there a correlation? Results of an artificial neural 
network analysis. Eur Urol, 2011. 60(2): p. 253-60. 
43. Mouritsen, L., Classification and evaluation of prolapse. Best Pract Res Clin 
Obstet Gynaecol, 2005. 19(6): p. 895-911. 
44. Romanzi, L.J., D.C. Chaikin, and J.G. Blaivas, The effect of genital prolapse on 
voiding. J Urol, 1999. 161(2): p. 581-6. 
45. Richardson, A.C., P.B. Edmonds, and N.L. Williams, Treatment of stress 
urinary incontinence due to paravaginal fascial defect. Obstet Gynecol, 1981. 
57(3): p. 357-62. 
46. DeLancey, J.O., Structural support of the urethra as it relates to stress urinary 
incontinence: the hammock hypothesis. Am J Obstet Gynecol, 1994. 170(6): p. 
1713-20 
47. Delancey, J.O., Fascial and muscular abnormalities in women with urethral 
hypermobility and anterior vaginal wall prolapse. Am J Obstet Gynecol, 2002. 
187(1): p. 93-8. 
48. Richardson, D.A., A.E. Bent, and D.R. Ostergard, The effect of uterovaginal 
prolapse on urethrovesical pressure dynamics. Am J Obstet Gynecol, 1983. 
146(8): p. 901-5. 
49. Liang, C.C., et al., Pessary test to predict postoperative urinary incontinence in 
women undergoing hysterectomy for prolapse. Obstet Gynecol, 2004. 104(4): p. 
795-800. 
50. Reena, C., A.N. Kekre, and N. Kekre, Occult stress incontinence in women with 
pelvic organ prolapse. Int J Gynaecol Obstet, 2007. 97(1): p. 31-4. 
51. Visco, A.G., et al., The role of preoperative urodynamic testing in stress-
continent women undergoing sacrocolpopexy: the Colpopexy and Urinary 
Reduction Efforts (CARE) randomized surgical trial. Int Urogynecol J Pelvic 
Floor Dysfunct, 2008. 19(5): p. 607-14. 
52. de Tayrac, R., et al., Combined genital prolapse repair reinforced with a 
polypropylene mesh and tension-free vaginal tape in women with genital 
prolapse and stress urinary incontinence: a retrospective case-control study 
with short-term follow-up. Acta Obstet Gynecol Scand, 2004. 83(10): p. 950-4. 
53. Maher, C.M., et al., Surgical management of pelvic organ prolapse in women: 
the updated summary version Cochrane review. Int Urogynecol J, 2011. 22(11): 
p. 1445-57. 
54. Chaikin, D.C., A. Groutz, and J.G. Blaivas, Predicting the need for anti-
incontinence surgery in continent women undergoing repair of severe 
urogenital prolapse. J Urol, 2000. 163(2): p. 531-4. 
55. Rosenzweig, B.A., et al., Prevalence of abnormal urodynamic test results in 
continent women with severe genitourinary prolapse. Obstet Gynecol, 1992. 
79(4): p. 539-42. 
56. Gallentine, M.L. and R.D. Cespedes, Occult stress urinary incontinence and the 
effect of vaginal vault prolapse on abdominal leak point pressures. Urology, 
2001. 57(1): p. 40-4. 
57. Romanzi, L.J., Management of the urethral outlet in patients with severe 
prolapse. Curr Opin Urol, 2002. 12(4): p. 339-44. 
58. Veronikis, D.K., D.H. Nichols, and M.M. Wakamatsu, The incidence of low-
pressure urethra as a function of prolapse-reducing technique in patients with 
   63 
massive pelvic organ prolapse (maximum descent at all vaginal sites). Am J 
Obstet Gynecol, 1997. 177(6): p. 1305-13 
59. Bump, R.C., J.A. Fantl, and W.G. Hurt, The mechanism of urinary continence 
in women with severe uterovaginal prolapse: results of barrier studies. Obstet 
Gynecol, 1988. 72(3 Pt 1): p. 291-5. 
60. Meschia, M., et al., A randomized comparison of tension-free vaginal tape and 
endopelvic fascia plication in women with genital prolapse and occult stress 
urinary incontinence. Am J Obstet Gynecol, 2004. 190(3): p. 609-13. 
61. Wall, L.L. and J.K. Hewitt, Urodynamic characteristics of women with 
complete posthysterectomy vaginal vault prolapse. Urology, 1994. 44(3): p. 
336-41 
62. Roovers, J.P. and M. Oelke, Clinical relevance of urodynamic investigation 
tests prior to surgical correction of genital prolapse: a literature review. Int 
Urogynecol J Pelvic Floor Dysfunct, 2007. 18(4): p. 455-60. 
63. Carter, P.G., P. Lewis, and P. Abrams, Urodynamic morbidity and dysuria 
prophylaxis. Br J Urol, 1991. 67(1): p. 40-1. 
64. Okorocha, I., G. Cumming, and I. Gould, Female urodynamics and lower 
urinary tract infection. BJU Int, 2002. 89(9): p. 863-7. 
65. Weber, A.M. and M.D. Walters, Cost-effectiveness of urodynamic testing 
before surgery for women with pelvic organ prolapse and stress urinary 
incontinence. Am J Obstet Gynecol, 2000. 183(6): p. 1338-46;  
66. Bump, R.C., et al., The standardization of terminology of female pelvic organ 
prolapse and pelvic floor dysfunction. Am J Obstet Gynecol, 1996. 175(1): p. 
10-7. 
67. Swift, S., et al., Validation of a simplified technique for using the POPQ pelvic 
organ prolapse classification system. Int Urogynecol J Pelvic Floor Dysfunct, 
2006. 17(6): p. 615-20. 
68. Shull, B.L., et al., A transvaginal approach to repair of apical and other 
associated sites of pelvic organ prolapse with uterosacral ligaments. Am J 
Obstet Gynecol, 2000. 183(6): p. 1365-73 
69. Whiteside, J.L., et al., Risk factors for prolapse recurrence after vaginal repair. 
Am J Obstet Gynecol, 2004. 191(5): p. 1533-8. 
70. Morrisroe, S., U. Lee, and S. Raz, The use of mesh in vaginal prolapse repair: 
do the benefits justify the risks? Curr Opin Urol, 2010. 20(4): p. 275-9. 
71. Chmielewski, L., et al., Reanalysis of a randomized trial of 3 techniques of 
anterior colporrhaphy using clinically relevant definitions of success. Am J 
Obstet Gynecol, 2011. 205(1): p. 69 e1-8. 
72. Boyles, S.H., A.M. Weber, and L. Meyn, Procedures for pelvic organ prolapse 
in the United States, 1979-1997. Am J Obstet Gynecol, 2003. 188(1): p. 108-15. 
73. Maher, C., et al., Surgical management of pelvic organ prolapse in women. 
Cochrane Database of Systematic Reviews, (4). 
74. Kelly, Incontinence of urine in women. Urol Cutan Rev, 1913. 1: p. 291-3. 
75. Bruce, R.G., R.E. El-Galley, and N.T. Galloway, Paravaginal defect repair in 
the treatment of female stress urinary incontinence and cystocele. Urology, 
1999. 54(4): p. 647-51. 
76. Julian, T.M., The efficacy of Marlex mesh in the repair of severe, recurrent 
vaginal prolapse of the anterior midvaginal wall. Am J Obstet Gynecol, 1996. 
175(6): p. 1472-5. 
77. Mallipeddi, P.K., et al., Anatomic and functional outcome of vaginal 
paravaginal repair in the correction of anterior vaginal wall prolapse. Int 
Urogynecol J Pelvic Floor Dysfunct, 2001. 12(2): p. 83-8. 
 64 
78. Young, S.B., J.J. Daman, and L.G. Bony, Vaginal paravaginal repair: one-year 
outcomes. Am J Obstet Gynecol, 2001. 185(6): p. 1360-6. 
79. Chen, C.C., B. Ridgeway, and M.F. Paraiso, Biologic grafts and synthetic 
meshes in pelvic reconstructive surgery. Clin Obstet Gynecol, 2007. 50(2): p. 
383-411. 
80. Burger, J.W., et al., Long-term follow-up of a randomized controlled trial of 
suture versus mesh repair of incisional hernia. Ann Surg, 2004. 240(4): p. 578-
83. 
81. Emge, L.A. and R.B. Durfee, Pelvic organ prolapse: four thousand years of 
treatment. Clin Obstet Gynecol, 1966. 9(4): p. 997-1032. 
82. Debodinance, P., et al., [Synthetic meshes for transvaginal surgical cure of 
genital prolapse: evaluation in 2005]. J Gynecol Obstet Biol Reprod (Paris), 
2006. 35(5 Pt 1): p. 429-54. 
83. Foon, R. and P. Smith, The effectiveness and complications of graft materials 
used in vaginal prolapse surgery. Curr Opin Obstet Gynecol, 2009. 21(5): p. 
424-7. 
84. Amid, P.K. and I.L. Lichtenstein, [Current assessment of Lichtenstein tension-
free hernia repair]. Chirurg, 1997. 68(10): p. 959-64. 
85. Goldstein, H.S., A university experience using mesh in inguinal hernia repair. 
Hernia, 2001. 5(4): p. 182-5. 
86. Griffis, K. and D.S. Hale, Grafts in pelvic reconstructive surgery. Clin Obstet 
Gynecol, 2005. 48(3): p. 713-23. 
87. Falconer, C., et al., Clinical outcome and changes in connective tissue 
metabolism after intravaginal slingplasty in stress incontinent women. Int 
Urogynecol J Pelvic Floor Dysfunct, 1996. 7(3): p. 133-7. 
88. Rosch, R., et al., Mesh implants in hernia repair. Inflammatory cell response in 
a rat model. Eur Surg Res, 2003. 35(3): p. 161-6. 
89. Herschorn, S., The use of biological and synthetic materials in vaginal surgery 
for prolapse. Curr Opin Urol, 2007. 17(6): p. 408-14. 
90. Altman, D., et al., Anterior colporrhaphy versus transvaginal mesh for pelvic-
organ prolapse. N Engl J Med. 364(19): p. 1826-36. 
91. Carey, M., et al., Vaginal repair with mesh versus colporrhaphy for prolapse: a 
randomised controlled trial. BJOG, 2009. 116(10): p. 1380-6. 
92. Elmer, C., et al., Trocar-guided transvaginal mesh repair of pelvic organ 
prolapse. Obstet Gynecol, 2009. 113(1): p. 117-26. 
93. Jacquetin, B., et al., Total transvaginal mesh (TVM) technique for treatment of 
pelvic organ prolapse: a 3-year prospective follow-up study. Int Urogynecol J, 
2010. 21(12): p. 1455-62. 
94. Moore, R.D., et al., Prospective multicenter trial assessing type I, 
polypropylene mesh placed via transobturator route for the treatment of 
anterior vaginal prolapse with 2-year follow-up. Int Urogynecol J, 2010. 21(5): 
p. 545-52. 
95. Nguyen, J.N. and R.J. Burchette, Outcome after anterior vaginal prolapse 
repair: a randomized controlled trial. Obstet Gynecol, 2008. 111(4): p. 891-8. 
96. Nieminen, K., et al., Outcomes after anterior vaginal wall repair with mesh: a 
randomized, controlled trial with a 3 year follow-up. Am J Obstet Gynecol, 
2010. 203(3): p. 235 e1-8. 
97. Withagen, M.I., et al., Trocar-guided mesh compared with conventional vaginal 
repair in recurrent prolapse: a randomized controlled trial. Obstet Gynecol, 
2011. 117(2 Pt 1): p. 242-50. 
   65 
98. Jia, X., et al., Efficacy and safety of using mesh or grafts in surgery for anterior 
and/or posterior vaginal wall prolapse: systematic review and meta-analysis. 
BJOG, 2008. 115(11): p. 1350-61. 
99. Dennerstein, L., J.L. Alexander, and K. Kotz, The menopause and sexual 
functioning: a review of the population-based studies. Annu Rev Sex Res, 
2003. 14: p. 64-82. 
100. Sobhgol, S.S. and S.M. Alizadeli Charndabee, Rate and related factors of 
dyspareunia in reproductive age women: a cross-sectional study. Int J Impot 
Res, 2007. 19(1): p. 88-94. 
101. Weber, A.M., M.D. Walters, and M.R. Piedmonte, Sexual function and vaginal 
anatomy in women before and after surgery for pelvic organ prolapse and 
urinary incontinence. Am J Obstet Gynecol, 2000. 182(6): p. 1610-5. 
102. Handa, V.L., et al., Sexual function before and after sacrocolpopexy for pelvic 
organ prolapse. Am J Obstet Gynecol, 2007. 197(6): p. 629 e1-6. 
103. Silva, W.A., et al., Uterosacral ligament vault suspension: five-year outcomes. 
Obstet Gynecol, 2006. 108(2): p. 255-63. 
104. Maher, C., et al., Surgical management of pelvic organ prolapse in women: a 
short version Cochrane review. Neurourol Urodyn, 2008. 27(1): p. 3-12. 
105. Fayyad, A.M., et al., Prospective study of anterior transobturator mesh kit 
(Prolift) for the management of recurrent anterior vaginal wall prolapse. Int 
Urogynecol J, 2011. 22(2): p. 157-63. 
106. Milani, A.L., M.I. Withagen, and M.E. Vierhout, Trocar-guided total tension-
free vaginal mesh repair of post-hysterectomy vaginal vault prolapse. Int 
Urogynecol J Pelvic Floor Dysfunct, 2009. 20(10): p. 1203-11. 
107. Altman, D., et al., Sexual dysfunction after trocar-guided transvaginal mesh 
repair of pelvic organ prolapse. Obstet Gynecol, 2009. 113(1): p. 127-33. 
108. Feiner, B., L. Gietelink, and C. Maher, Anterior vaginal mesh sacrospinous 
hysteropexy and posterior fascial plication for anterior compartment dominated 
uterovaginal prolapse. Int Urogynecol J, 2010. 21(2): p. 203-8. 
109. Aungst, M.J., et al., De novo stress incontinence and pelvic muscle symptoms 
after transvaginal mesh repair. Am J Obstet Gynecol, 2009. 201(1): p. 73 e1-7. 
110. de Landsheere, L., et al., Surgical intervention after transvaginal Prolift mesh 
repair: retrospective single-center study including 524 patients with 3 years' 
median follow-up. Am J Obstet Gynecol, 2011. 
111. Abed, H., et al., Incidence and management of graft erosion, wound 
granulation, and dyspareunia following vaginal prolapse repair with graft 
materials: a systematic review. Int Urogynecol J, 2011. 22(7): p. 789-98. 
112. Achtari, C., et al., Risk factors for mesh erosion after transvaginal surgery 
using polypropylene (Atrium) or composite polypropylene/polyglactin 910 
(Vypro II) mesh. Int Urogynecol J Pelvic Floor Dysfunct, 2005. 16(5): p. 389-
94. 
113. Araco, F., G. Gravante, and E. Piccione, Bladder erosion after 2 years from 
cystocele repair with type I polypropylene mesh. Int Urogynecol J Pelvic Floor 
Dysfunct, 2009. 20(6): p. 731-3. 
114. Belot, F., et al., [Risk factors for prosthesis exposure in treatment of genital 
prolapse via the vaginal approach]. Gynecol Obstet Fertil, 2005. 33(12): p. 
970-4. 
115. Schafer, W., et al., Good urodynamic practices: uroflowmetry, filling 
cystometry, and pressure-flow studies. Neurourol Urodyn, 2002. 21(3): p. 261-
74. 
 66 
116. Lose, G., et al., Standardisation of urethral pressure measurement: report from 
the Standardisation Sub-Committee of the International Continence Society. 
Neurourol Urodyn, 2002. 21(3): p. 258-60. 
117. Shumaker, S.A., et al., Health-related quality of life measures for women with 
urinary incontinence: the Incontinence Impact Questionnaire and the 
Urogenital Distress Inventory. Continence Program in Women (CPW) 
Research Group. Qual Life Res, 1994. 3(5): p. 291-306. 
118. Kasturi, S., et al., De novo stress urinary incontinence after negative prolapse 
reduction stress testing for total vaginal mesh procedures: incidence and risk 
factors. Am J Obstet Gynecol, 2011. 205(5): p. 487 e1-4. 
119. Weber, A.M., Is urethral pressure profilometry a useful diagnostic test for 
stress urinary incontinence? Obstet Gynecol Surv, 2001. 56(11): p. 720-35. 
120. Colli, E., et al., Are urodynamic tests useful tools for the initial conservative 
management of non-neurogenic urinary incontinence? A review of the 
literature. Eur Urol, 2003. 43(1): p. 63-9. 
121. Caruso, D.J., et al., What is the predictive value of urodynamics to reproduce 
clinical findings of urinary frequency, urge urinary incontinence, and/or stress 
urinary incontinence? Int Urogynecol J, 2010. 21(10): p. 1205-9. 
122. Khan, M.S., et al., The relationship between urinary symptom questionnaires 
and urodynamic diagnoses: an analysis of two methods of questionnaire 
administration. BJOG, 2004. 111(5): p. 468-74. 
123. Ek, M., et al., Urodynamic assessment of anterior vaginal wall surgery: A 
randomized comparison between colporraphy and transvaginal mesh. 
Neurourol Urodyn, 2009. 
124. Hiltunen, R., et al., Low-weight polypropylene mesh for anterior vaginal wall 
prolapse: a randomized controlled trial. Obstet Gynecol, 2007. 110(2 Pt 2): p. 
455-62. 
125. Iglesia, C.B., et al., Vaginal mesh for prolapse: a randomized controlled trial. 
Obstet Gynecol, 2010. 116(2 Pt 1): p. 293-303. 
126. Haylen, B.T., et al., An International Urogynecological Association 
(IUGA)/International Continence Society (ICS) joint report on the terminology 
for female pelvic floor dysfunction. Neurourol Urodyn, 2010. 29(1): p. 4-20. 
127. Sivaslioglu, A.A., E. Unlubilgin, and I. Dolen, A randomized comparison of 
polypropylene mesh surgery with site-specific surgery in the treatment of 
cystocoele. Int Urogynecol J Pelvic Floor Dysfunct, 2008. 19(4): p. 467-71. 
128. Moore, R.D. and J.R. Miklos, Vaginal repair of cystocele with anterior wall 
mesh via transobturator route: efficacy and complications with up to 3-year 
followup. Adv Urol, 2009: p. 743831. 
129. Shek, K.L., et al., Stress urinary incontinence after transobturator mesh for 
cystocele repair. Int Urogynecol J Pelvic Floor Dysfunct, 2009. 20(4): p. 421-5. 
130. Fatton, B., et al., Transvaginal repair of genital prolapse: preliminary results of 
a new tension-free vaginal mesh (Prolift technique)--a case series multicentric 
study. Int Urogynecol J Pelvic Floor Dysfunct, 2007. 18(7): p. 743-52. 
131. van Raalte, H.M., et al., One-year anatomic and quality-of-life outcomes after 
the Prolift procedure for treatment of posthysterectomy prolapse. Am J Obstet 
Gynecol, 2008. 199(6): p. 694 e1-6. 
132. Bradley, C.S. and I.E. Nygaard, Vaginal wall descensus and pelvic floor 
symptoms in older women. Obstet Gynecol, 2005. 106(4): p. 759-66. 
133. Mouritsen, L. and J.P. Larsen, Symptoms, bother and POPQ in women referred 
with pelvic organ prolapse. Int Urogynecol J Pelvic Floor Dysfunct, 2003. 
14(2): p. 122-7. 
   67 
134. Digesu, G.A., et al., Do overactive bladder symptoms improve after repair of 
anterior vaginal wall prolapse? Int Urogynecol J Pelvic Floor Dysfunct, 2007. 
18(12): p. 1439-43. 
135. Nguyen, J.K. and N.N. Bhatia, Resolution of motor urge incontinence after 
surgical repair of pelvic organ prolapse. J Urol, 2001. 166(6): p. 2263-6. 
136. Milani, R., et al., Functional and anatomical outcome of anterior and posterior 
vaginal prolapse repair with prolene mesh. BJOG, 2005. 112(1): p. 107-11. 
137. Petros, P.E. and U.I. Ulmsten, An integral theory of female urinary 
incontinence. Experimental and clinical considerations. Acta Obstet Gynecol 
Scand Suppl, 1990. 153: p. 7-31. 
138. Brading, A.F., A myogenic basis for the overactive bladder. Urology, 1997. 
50(6A Suppl): p. 57-67. 
139. White, A., Cystocele. JAMA, 1909. 21: p. 1707-1710. 
140. Richardson, A.C., J.B. Lyon, and N.L. Williams, A new look at pelvic 
relaxation. Am J Obstet Gynecol, 1976. 126(5): p. 568-73. 
141. Barber, M.D., et al., Accuracy of clinical assessment of paravaginal defects in 
women with anterior vaginal wall prolapse. Am J Obstet Gynecol, 1999. 
181(1): p. 87-90. 
142. Nguyen, J.K., Current concepts in the diagnosis and surgical repair of anterior 
vaginal prolapse due to paravaginal defects. Obstet Gynecol Surv, 2001. 56(4): 
p. 239-46. 
143. Segal, J.L., et al., Paravaginal defects: prevalence and accuracy of 
preoperative detection. Int Urogynecol J Pelvic Floor Dysfunct, 2004. 15(6): p. 
378-83. 
144. Summers, A., et al., The relationship between anterior and apical compartment 
support. Am J Obstet Gynecol, 2006. 194(5): p. 1438-43. 
145. Dietz, H.P., et al., Paravaginal defects: a comparison of clinical examination 
and 2D/3D ultrasound imaging. Aust N Z J Obstet Gynaecol, 2005. 45(3): p. 
187-90. 
146. Larson, K.A., et al., 3D analysis of cystoceles using magnetic resonance 
imaging assessing midline, paravaginal, and apical defects. Int Urogynecol J, 
2012. 23(3): p. 285-93. 
147. Morse, A.N., et al., Midline anterior repair alone vs anterior repair plus 
vaginal paravaginal repair: a comparison of anatomic and quality of life 
outcomes. Int Urogynecol J Pelvic Floor Dysfunct, 2007. 18(3): p. 245-9. 
148. Whiteside, J.L., et al., Clinical evaluation of anterior vaginal wall support 
defects: interexaminer and intraexaminer reliability. Am J Obstet Gynecol, 
2004. 191(1): p. 100-4. 
149. Jackson, R.A., et al., Urinary incontinence in elderly women: findings from the 
Health, Aging, and Body Composition Study. Obstet Gynecol, 2004. 104(2): p. 
301-7. 
150. Hendrix, S.L., et al., Effects of estrogen with and without progestin on urinary 
incontinence. JAMA, 2005. 293(8): p. 935-48. 
151. Kearney, R., et al., Obstetric factors associated with levator ani muscle injury 
after vaginal birth. Obstet Gynecol, 2006. 107(1): p. 144-9. 
 
 
 
 
 68 
14  APPENDIX 
14.1 POP-Q protocol paper I-IV 
POP-Q kvantifiering enligt ICS-standardisation committee. 
 
A 
 
BA 
 
C 
 
gh 
 
P 
 
tvl 
 
Ap 
 
Bp 
 
D 
 
 
Anser du att det föreligger en lateral sänkning av vaginalväggen (lateral defekt):     
  □ Ja      □  Nej 
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14.2 Urodynamic protocol paper I 
 
Urodynamisk us TVM III 
 
Tilldelat randomiseringsnummer……………… 
Datum för undersökning…………………………… 
Sjukhus……………………………………………. 
Preoperativ us 
 
     Postoperativ us 
1. Mätning av resurin (ml) 
 
 
2. Maximal cystometrisk 
blåskapacitet (ml) 
 
 
      Ja Nej 
3. Detrusor kontraktioner under 
fyllnadsfasen 
 
 
4.  Lätta trängningar vid    Volym…………… 
5. Starka trängningar vid    Volym…………… 
6. Avtappning av blåsan till 300 ml  
7. Urethratryckprofiler  
MUCP (maximum urethral closing 
pressure) 
 
    ……………………..cm H2O 
    Ja Nej 
8. Hostläckage vid hostprovokation 
med kateter borttagen (ca 300 ml 
i blåsan) 
 
9. Q-max (flödesmätning)     ………………….. (ml/s) 
10. Resurin     ……………………(ml) 
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14.3 Questionnaire paper II-IV, UDI original form. 
Följande frågor avser att undersöka i vilken utsträckning du upplever symptom från 
bäckenbotten och nedre urinvägarna: 
 Nej Om Ja, hur mycket besvärar det Dig? 
  Inte alls Lite Måttligt Mycket 
Upplever du att du kissar ofta? □ □ □ □ □ 
Har du stark känsla av 
urinträngning? 
□ □ □ □ □ 
Upplever du urinläckage vid 
trängning? 
□ □ □ □ □ 
Läcker det urin vid fysisk 
ansträngning, hosta? 
□ □ □ □ □ 
Läcker urin utan relation till 
aktivitet? 
□ □ □ □ □ 
Läcker det urin droppvis? □ □ □ □ □ 
Läcker det stora mängder urin? □ □ □ □ □ 
Går du upp på natten för att 
kissa? 
□ □ □ □ □ 
Upplever du sängvätning? □ □ □ □ □ 
Upplever du svårigheter att 
tömma blåsan? 
□ □ □ □ □ 
Kan det kännas som om blåsan 
inte är tömd? 
□ □ □ □ □ 
Upplever du ett tryck i nedre 
delen av buken? 
□ □ □ □ □ 
Kan det göra ont när du kissar? □ □ □ □ □ 
Har du värk i underlivet? □ □ □ □ □ 
Har du tyngdkänsla i 
underlivet? 
□ □ □ □ □ 
Känns det som om något 
buktar i underlivet? 
□ □ □ □ □ 
Erfar du obehag i underlivet i 
stående eller vid fysisk 
ansträngning? 
□ □ □ □ □ 
Måste du trycka i slidan för att 
tömma tarmen? 
□ □ □ □ □ 
 
 
